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ABSTRACT 
 According to the latest World Health Organization (WHO) statistics, breast cancer is the 
most common type of cancer among women worldwide (1). The WHO has further emphasized 
that early diagnosis and treatment are key in mitigating the burden of disease (2). In spite of this 
assessment, the standard histopathology of breast cancer still relies on manual microscopic 
examination of stained tissue. Being qualitative and manual in nature, this standard diagnostic 
procedure can suffer from inter-observer variation and low-throughput (3). In addition, stain 
variation between different samples and different laboratories creates problems for supervised 
image analysis methods for automated diagnosis. A quantitative, label-free and automatable 
microscopic modality for breast cancer diagnosis is, thus, needed to address these 
shortcomings in the standard method. 
 Furthermore, prognostic biomarkers are important tools used by clinicians in order assess 
the disease course in patients (4). Being correlated with outcomes, these markers allow 
pathologists to determine aggressiveness of disease and tailor treatment accordingly. However, the 
current set of biomarkers for breast cancer are ineffective in predicting outcomes in all patients 
and there is a need for additional markers of prognosis to better account for variation among 
individuals (5, 6). Microscopic and imaging tools for extracting new, quantitative biomarkers 
during breast histopathology are, thus, also desirable.  
 Although a number of new quantitative imaging modalities for diagnostic and prognostic 
evaluations have been proposed, a key challenge remains compatibility with the existing workflow 
for easier clinical translation. Quantitative methods that minimally affect the clinical pipeline 
already in place are expected to have a greater impact than those that require significant 
new infrastructure. 
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 During my graduate work I have approached these problems in modern breast 
histopathology by using quantitative phase imaging (QPI). QPI is a label-free microscopy 
technique where image contrast is generated by measuring the optical path-length difference 
(OPD) across the specimen. OPD refers to the product of the refractive index and thickness at a 
point in the field of view. Since this measurement relies on a physical property of tissue and is 
label-free, it provides an objective and potentially automatable basis for tissue assessment. We 
employ a QPI technique called Spatial Light Interference Microscopy (SLIM) for investigations 
carried out during this thesis research. 
The specific aims of my thesis research are: 
1. Label-free quantitative evaluation of breast biopsies using SLIM: In this work, we show by 
imaging a tissue microarray (TMA) that our QPI based method can separate benign and malignant 
cases by relying on tissue OPD based features. By employing image processing and statistical 
learning, we demonstrate a label-free quantitative diagnosis scheme that can provide an objective 
basis for tissue assessment. A quantitative method like this can also, potentially, be automated, 
reducing case-load for pathologists by automatically flagging problematic cases that require 
further investigation. 
2. Quantifying tumor adjacent collagen structure in breast tissue using SLIM: Recent 
evidence shows that the structure of tumor adjacent collagen fibers influences tumor progression. 
In particular, collagen fiber alignment and orientation can facilitate epithelial invasion to 
surrounding tissue (5). We demonstrate that SLIM can be used to detect this prognostic marker 
that in the past had been detected using Second Harmonic Generation Microscopy (SHGM). Our 
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SLIM based method improves on the SHGM based method in terms of throughput and the fact 
that cellular information can be obtained, in addition to collagen fiber structure, in a single image.   
3. Quantitative histopathology on stained tissue biopsies: The instruments and image analysis 
tools developed in Aims 1 and 2 are designed for unstained tissue biopsies. Since standard tissue 
histopathology inevitably requires staining, we aim to demonstrate that we can extend these tools 
to stained tissue biopsies. In this way, the standard diagnostic workflow will be minimally 
disrupted. In addition, from a single shot, both an OPD map and stained tissue bright field image 
will be obtainable for evaluation. We demonstrate that QPI images of stained tissue can be used to 
solve diagnostic and prognostic problems in breast tissue assessment, using quantitative markers. 
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CHAPTER 1: Introduction 
1.1 Background and Significance 
 According to the latest figures of the International Agency for Research on Cancer (IARC) 
– a part of the WHO – breast cancer is the most commonly diagnosed cancer among women in 
both the developed and the developing world (1). The American Cancer Society predicts that in 
2018 around 266,120 new cases of invasive breast cancer will be diagnosed among women in the 
United States (7). While mortality rates due to breast cancer within the US have been consistently 
falling over the years, rates of incidence have been on the rise (7). This rise in incidence means 
that an increasing number of follow-up patient investigations will be performed, increasing the 
case-load for pathology labs. Effective treatment strategies for breast cancer patients require timely 
diagnosis and prognosis of the disease. It has been reported that, in the US, the 5-year average 
survival rates for patients with invasive breast cancers increase from 90% to 99% when the disease 
is detected at a localized (non-metastatic) stage (8). In addition, for difficult and borderline cases 
there still exists disagreement between pathologists as to what the patient diagnosis should be (9, 
10). In this context, tools that improve on the standard histopathology method in terms of speed, 
sensitivity, specificity and timely diagnosis and treatment are vital for mitigating the burden of 
disease.  
 Standard histopathology of breast tissue involves microscopic examination of a stained 
tissue biopsy by a trained clinical pathologist. These biopsies are surgically obtained after the 
patient shows an abnormality during a screening procedure such as X-ray mammography. A 
number of tissue preparation steps occur between surgical extraction and pathologist evaluation. 
The tissue is dehydrated, fixed in formalin and embedded in paraffin. The resulting processed 
tissue is referred to as formalin fixed and paraffin embedded (FFPE) tissue (11). Next, thin sections 
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of tissue (4-5 μm) are prepared by serial sectioning of the tissue block using a microtome, in 
preparation for staining. Staining of tissue is a vital component of the processing since cells and 
tissues neither absorb nor scatter light significantly, leading to poor contrast under a conventional 
microscope, in the absence of staining. The most commonly used stain in a pathology lab is 
hematoxylin and eosin (H&E). The stain was first discovered in 1876 by Wissowzky and remains 
to this day the most commonly used contrast mechanism during histopathology (12). Hematoxylin 
stains the cell nuclei blue/purple whereas eosin stains proteins within tissue pink thus generating 
contrast for the cell cytoplasm as well as the extra-cellular matrix (13). After staining, the tissue 
section is examined under a microscope by a pathologist who looks for morphological 
abnormalities indicative of disease. If the presence of disease is suspected, a parallel section of 
tissue is stained with immunohistochemical (IHC) markers for converging to a final diagnosis. 
IHC staining has a higher specificity than H&E and can therefore be used to answer specific 
questions regarding tissue pathology (14). 
  This standard tissue assessment method has a number for shortcomings. First, the 
pathologist evaluation relies on qualitative information, which means that there can be inter-
observer variation during microscopic examination (9, 15). This is particularly challenging for 
borderline and difficult cases since, in the absence of quantification, agreement on the patient 
diagnosis is difficult to achieve. Second, the investigation is manual which leads to lower 
throughput that can potentially be achieved through automated or computer-aided analysis. 
Finally, the tissue preparation, especially stain intensity, can vary from lab to lab as well as from 
specimen to specimen (16-18). While trained pathologists are able to account for the resulting 
variations in image contrast, automated analysis through supervised learning schemes is made 
difficult in the absence of consistent image feature values (19). Even though a whole field, referred 
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to as “Digital Pathology”, has emerged out of the efforts to automate analysis of H&E stained 
tissue images, stain normalization is still an active area of research due to the lack of clear 
agreement on the best practices (20). 
 Another key challenge in breast pathology is tumor heterogeneity (21, 22). Breast tumors 
are more varied than other solid tumors resulting in large variations in responses to treatments 
between patients. For example, a number of breast cancer patients respond to hormonal therapies 
that target hormone receptors (HER2, estrogen and progesterone receptors) expressed by cells 
undergoing malignant transformation. However, for a molecular sub-type referred to as triple 
negative breast cancer, these therapies fail due to the absence of the hormone receptors in the cells 
being targeted (23). For these and other cases, pathologists rely on prognostic markers that are 
indicative of tumor aggressiveness and disease subtype. While effective in determining disease 
aggressiveness for a significant number of patients, due to disease heterogeneity, the current set of 
markers used for breast cancer prognosis (such as histological grade, hormone receptor status, Ki-
67 expression) are not able to determine disease course for all patients (5, 24). There is a need for 
expanding on the current set of markers in order to better predict outcomes and to tailor therapies 
to the needs of individuals based on their prognostication (6). As ever, these markers need to be 
quantitative and the assessment rapid and reproducible in order to be effectively used in the clinic 
(24). New histological markers can potentially play an important role in this regard and represent 
an opportunity. 
 Novel quantitative, label-free microscopy techniques can potentially address these 
limitations of/opportunities in standard histopathology of breast tissue. Relying on intrinsic 
contrast that is related to physical property of the tissue, these methods remove subjectivity from 
tissue assessment by relying on quantitative information (3). In addition, inconsistency in image 
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pixel values due to variations stain intensity, choice of white balancing method and illumination 
source variations are also minimized in label-free microscopy. This makes it easier to design and 
train machine learning classifiers that are able to rely on features that are consistent between 
training and deployment (25, 26). Automated image analysis through such classifiers can, 
therefore, also potentially improve the throughput of investigation (26). In addition, since these 
methods rely on new and different contrast mechanisms to those used in conventional microscopy, 
they can aid in the development of new image based markers (as yet unknown in traditional 
histopathology) for expanding on the current set of prognostic markers (5). A key design challenge 
in these new imaging modalities is compatibility with the current clinical pipeline for breast 
histopathology. Clinical translation will be difficult for modalities that require significant changes 
in the current method in terms of sample preparation and additional instrumentation. 
 QPI is a quantitative microscopy modality which generates contrast by mapping the optical 
path-length variation across the tissue specimen (27). In most cases QPI systems are built as add-
on modules to commercial microscopes and require minimal modifications in the current clinical 
diagnostic pipeline with regards to tissue processing and optical instrumentation. These systems 
also provide diffraction limited resolution and sub-nanometer sensitivity to tissue optical path-
length changes (27). Although a number of other imaging modalities have been developed and 
applied for quantitative histopathology, QPI has advantages over them in terms of resolution, speed 
and compatibility with the standard workflow in a pathology lab (see Section 2.5 for a detailed 
comparison of the different quantitative microscopy techniques used for histopathology).  
 In this thesis, I have attempted to use QPI to address the above-mentioned 
challenges/opportunities in histopathology of the breast. Making developments in both 
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instrumentation and computational tools, I have investigated a number of questions related to 
breast cancer diagnosis and prognosis as outlined below. 
1.2 Thesis Overview 
 This thesis is organized as follows. In Chapter 2 I provide an introduction to QPI, touching 
on the operating principle and the detection method. I also provide a comparison of QPI with other 
quantitative imaging techniques being used for tissue evaluation and review previous applications 
of QPI in clinical pathology. In Chapter 3, I discuss the application of QPI for qualitative 
evaluation of breast tissue. This is followed by Chapter 4 where this evaluation is conducted using 
quantitative markers and a supervised learning scheme for detecting malignancy in breast tissue  
images is introduced. In Chapter 5 I discuss a proof-of-principle study where we demonstrated that 
QPI can be used for detecting orientation of collagen fibers in breast tissue. The tools we developed 
in this work have applications in developing imaging markers for breast cancer prognosis. In 
Chapter 6, the imaging of stained tissue using QPI is introduced and it is demonstrated that the 
diagnostic and prognostic markers (shown to be effective in the earlier chapters on unstained 
tissue) are extendable to QPI maps of stained tissue. I end my thesis with Chapter 7 which explores 
the future questions that can be addressed in the field of breast histopathology using QPI, 
employing the instruments and algorithms developed in this thesis work. 
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Chapter 2: Quantitative Phase Imaging (QPI) 
 
2.1 Introduction 
Transparent specimen such as cells and tissues do not absorb or scatter light significantly 
and, thus, are difficult to resolve using intensity based detectors (such as CCD cameras, 
photodetectors, the human eye etc.)(28). One option for imaging such specimen is to generate 
exogenous contrast by using dyes and fluorescent molecules. However, not only do exogenous 
agents result in variability from sample to sample but fluorescence can lead to photo-toxicity and 
photo-bleaching (29). In 1942, Nobel laureate Fritz Zernike developed the phase contrast 
microscope, which generated intrinsic contrast in images by leveraging the phase of the 
electromagnetic field (30). While widely adopted by microscopists world-wide for label-free 
imaging, phase contrast images only provide qualitative information. The field of QPI was born 
out of attempts to quantitate the contrast generating mechanism in phase contrast microscopy. 
The interaction of light with transparent specimen (such as cells and tissues) involves a 
change in the phase of the electromagnetic field with respect to some reference. This phase shift 
is proportional to the integral, along the light propagation direction, of the difference between the 
refractive index of the specimen and that of the surrounding medium. Denoting the light 
propagation direction as the 𝑧-axis, the phase map ( , )x y  is given by 
  
 ( )
( )
( )
,
0
2
,  [ , ,  ]  
h x y
s mx y n x y z n dz



= −   (2.1) 
 
7 
 
where ( ), ,sn x y z  is the refractive index of the specimen as function of space, mn  is the refractive 
index of the surrounding medium,   is the wavelength of the illumination source and the 
integration limits span the thickness of the specimen ( ),h x y  (27, 31). 
 Over the years, a number of studies have shown that the refractive index of a cell, ( ), ,celln x y  
has a strong dependence on its total protein concentration ( ) ,x y . This relationship is given by 
 ( ) ( ),  ,   cell soln x y n x y= +   (2.2) 
where soln  is the refractive index of the cytoplasmic solvent and proportionality constant   is 
called the refractive increment (31-34). Since for most applications the difference between the 
refractive index of the cytoplasmic solvent and the cell immersion media is negligible ( 0 soln n ) it 
can be shown that the cell dry mass density ( ),x y   is proptional to the phase map ( ),x y  as (31, 
32, 35) 
 ( ) ( ),   , .  
2
x y x y



 =   (2.3) 
 These remarkable results have motivated several studies on cell-cycle dependent growth, 
dynamics of intracellular transport as well as chemical composition of cells though measurement 
of ( ),x y  and ( ),x y  using QPI (31, 35-39). The work presented in this chapter is based on the 
work in Ref. (31). 
2.2 Detection: Off-axis and phase shifting interferometry 
 Bright field microscopes, generally used in pathology, are only able to measure the 
intensity of the electric field. This is because all detectors (CCD, CMOS, retina) produce signals 
that are proportional to the time averaged magnitude square of the electric field and, as a result, 
fail to capture the phase information (28, 40, 41). QPI systems on the other hand generally exploit 
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spatial or temporal interferometry that can then be used to obtain both the magnitude and phase 
information of the image field.  
 Systems employing spatial interferometry are known as off-axis interferometers because 
they involve interference between the sample wave ( , )sU x y  and a plane wave reference rU  that is 
incident at an angle     to the sample wave propagation direction. This process is illustrated in Fig. 
2.1 (a). The two waves interfere at the detector plane and the resulting intensity distribution or 
interferogram is given by 
( ) ( ) ( ) ( )(
2 2
, ,  2 , cos[  ,s r r sI x y U x y U U U x y qx x y= + + +                (2.4) 
where 
2
sin  q



=  is the modulation frequency. ( ),x y  can be extracted from the acquired 
interferogram in two different ways depending on the specifics of the optical setup. In the first 
method, ( ),I x y  is measured at a conjugate image plane so that ( ),sU x y   represents the in-focus 
complex image field. In such a case, ( ),x y  can be obtained from the interferogram by first 
isolating the cross term in Eq. (2.4) using band-pass filtering and then taking the Hilbert transform 
of the result, as detailed in ref. (42). In a variant of this method, the camera is placed at a distance 
d  from the conjugate image plane in which case  ( , )sU x y  is the out-of-focus image field. In this 
case the complex image field associated with the object is obtained by first extracting ( , )sU x y  
from ( ),I x y  through the same process as in the first method and then obtaining the focused image 
field by numerically propagating ( , )sU x y  through a distance d by convolving with a Fresnel 
wavelet (43-45). ( ),x y  can then be obtained as the argument of the in-focus image. 
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 Systems employing temporal interferometry are referred to as phase-shifting 
interferometers. In these systems, the phase difference between the sample wave  ( , )sU x y  and the 
reference wave ( , )rU x y  is changed or shifted. Various devices can be used for this purpose [mobile 
mirror, liquid crystal phase modulator (LCPM), acousto-optic modulator etc.]. This interaction is 
illustrated in Fig. 2.1 (b). Denoting this tunable phase shift by  , the resulting interferogram at the 
detector plane is given by 
 2 2( , ; ) | ( , ) | | | 2 | ( , ) || | [ ( , ) ].s r s rI x y U x y U U x y U cos x y  = + + −   (2.5) 
Unambiguous determination of ( , ),x y  using phase-shifting interferometry, requires four different 
modulations (four frames). A common choice is to use 0, , ,
2 2
 
 
−
=  to acquire these four frames 
which can then be used to determine ( ),x y  as  
 ( )
( ) ( )
1
, ;   , ;
2 2
,  tan
, ;0  , ;
I x y I x y
x y
I x y I x y
 


−
    
− −    
    =
− 
  
. (2.6) 
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Figure 2.1 Principles of interferometric detection in QPI: (a) Off-axis interferometry (b) Phase-
shifting interferometry. LCPM: Liquid Crystal Phase Modulator. 
 
 Both off-axis and phase-shifting interferometry have their respective advantages and 
disadvantages that influence their adoption in various applications. Off-axis systems allow single-
shot measurements, therefore, improving the achievable acquisition rate over phase-shifting 
systems. However, these systems have coherence and spatial sampling requirements that result in 
smaller fields-of-view and lower resolutions than comparable phase-shifting interferometers (46, 
47). For the investigations discussed in this thesis, a phase shifting interferometer called SLIM has 
been used. SLIM combines the space-bandwidth advantages of phase-shifting interferometers with 
other merits, discussed below. 
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2.3 Spatial Light Interference Microscopy (SLIM) 
 Among phase-shifting interferometers, SLIM has had a number of applications for label-
free quantitative histopathology (see Section 2.4). Figure 2.2 illustrates the SLIM optical setup 
which has been discussed in detail in previous publications (48, 49). The setup comprises of a 
module (CellVista SLIM Pro, Phi Optics, Inc.) coupled to the output port of a commercial phase 
contrast microscope (in this thesis research Carl Zeiss, Axio Observer Z1 was used). This 
compatibility with existing microscopes promises to reduce barriers to clinical adoption since 
optical microscopes are commonly available in pathology labs. In the SLIM module, the 
conjugate image plane outside the microscope is relayed onto a sCMOS camera (Andor, Zyla) 
using a 4f system comprising lenses L1 and L2. At the Fourier plane of L1, a spatial light modulator 
(SLM, Boulder Nonlinear Systems) is used to modulate the phase difference between the scattered 
and unscattered components of light in increments of π/2. Four different modulations are applied 
[Fig. 2.2 (b)] and the resulting phase image is reconstructed as discussed in ref. (48). Using a 
software platform developed in-house, the SLIM module has been upgraded with full-slide 
scanning capabilities (50, 51). The scanning speed of the SLIM imaging system can be assessed 
by comparing it with that of a commercial slide scanner. For example, the Zeiss Axio Scan.Z1 
slide scanner is able to scan a 15x15 mm2 area, at 0.22 μm/pixel sampling rate, in 240 s. The 
SLIM system scans the same area at 0.125 μm/pixel in 1638 s. Scanning at the same resolution 
as the Zeiss instrument would improve the speed of the SLIM system by a factor of (0.22/0.125)2 
= 3.1, to 528s (51). Thus, our SLIM scanner is only a factor of 2.2 slower than the commercial 
Zeiss scanner, which is remarkable, especially considering that we record 4 intensity images for 
each SLIM image.  
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 Since SLIM relies on the same microscope optics as standard histopathology, the 
transverse resolution of the two systems is the same. Being a common-path, white-light based 
system (27), SLIM offers a spatial sensitivity of 0.28 nm and temporal sensitivity of 0.029 nm in 
terms of OPD (48). For histopathology, this implies that subtle (nanometer scale) changes in tissue 
OPD are detectable, which are correlated with on-set of malignancy and prognosis, as 
demonstrated in later chapters. 
 
 
Figure 2.2 (a) The SLIM module added on to a commercial phase contrast microscope. (b) Four 
frames are acquired to compute one phase image by modulating the phase difference between 
scattered and incident light using a spatial light modulator (SLM). (c) An image of the whole 
slide scanned using SLIM. (d) Example of a TMA core SLIM image. (e) Bright field image of 
the same core after H&E staining. BS, beam splitter; L1-L2, lenses; IP, image plane. 
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2.4 Previous work on quantitative histopathology using QPI 
 Quantitative phase images of tissue biopsies report on the OPD across the tissue specimen 
(Eq. 2.1). OPD of tissue describes its nanoscale architecture which can be expected to vary between 
healthy and diseased tissue as well as between different disease types. This has motivated several 
histopathological investigations of different organs using QPI which I briefly review here.  
 A majority of these studies have focused on diagnosis i.e separating diseased and normal 
tissue. In (52) Wang et al. showed that the median and mode of SLIM phase images vary 
significantly between benign and malignant prostate tissue. They also reported that phase images 
are able to generate contrast for calcium oxalate micro-calcifications in breast tissue. These 
calcifications are important for a pathologist to detect from a clinical point of view but are not 
visible on standard H&E stained bright-field images. In (53), an off-axis QPI technique called 
Hilbert Phase Microscopy (HPM) was used to extract phase images of healthy and diseased mouse 
liver tissue. Using refractive index maps extracted from these phase images, by assuming constant 
known tissue thickness (see Eq. 2.1), the authors showed that the spatial standard deviation of 
these maps was significantly different between normal liver tissue and liver tissue with lysosomal 
storage disease. Refractive index maps, extracted using a QPI technique called Spatial Low-
coherence Quantitative Phase Microscopy (SL-QPM), were also used by the authors of (54) to 
show that malignant breast epithelial cells have on average higher refractive index than benign 
breast epithelial cells. Takabayashi et al. showed, once again using SLIM, that normal breast tissue 
has a smaller ‘disorder strength’ than malignant breast tissue (55). This parameter was once again 
measured using QPI-derived refractive index maps and is inversely related to the strength of tissue 
scattering (55).  QPI images have also been used for diagnosing colorectal cancer. In (50), the 
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authors used the median phase value of each gland within colorectal tissue, imaged using SLIM, 
to separate benign, dysplastic and malignant cases.  
 While (55) and (54) have characterized differences in refractive index and scattering 
between benign and malignant breast tissue, a formal model for automated, supervised 
classification of diseased and non-diseased cases, using QPI, has as yet not been reported and is 
one of the aims of this thesis research.  
 On the prognosis front, Sridharan et al. used SLIM images of prostate tissue biopsies to 
investigate how the scattering properties of tissue vary between patients having recurrence and 
non-recurrence after prostatectomy (56). Their analysis showed that scattering anisotropy, 
measured from phase maps using the scattering phase theorem (57), was higher in non-recurrent 
cases compared to recurrent cases. Nguyen et al. used SLIM phase maps of prostate tissue biopsies 
to come up with a model for classifying tumors according to their Gleason grade. They used 
supervised learning to automate the process of tumor scoring (25). In a study focused on 
determining the future risk of developing colorectal cancer, the authors in (58) generated depth-
resolved OPD maps of tissue biopsies using SL-QPM. Using statistical parameters measured from 
these maps, they separated patients at high risk of developing colorectal cancer from those at low 
risk. To our knowledge, little to no work has been done on breast cancer prognosis using QPI, 
which is one of the aims of this thesis research. 
2.5 Competing label-free quantitative microscopy techniques 
  A number of other label-free contrast generating mechanisms have been proposed in the 
past for quantitative histopathology.  The three mostly widely used ones are: Fourier Transform 
Infra-Red Spectroscopic (FTIR) imaging, Raman Spectroscopic (RS) imaging and SHGM. In this 
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section, we briefly compare and contrast these techniques with QPI, highlighting their relative 
merits and demerits. 
 FTIR relies on the difference in absorption spectra across the tissue specimen to generate 
contrast. The absorption spectra vary for different tissue components due to their different 
chemical compositions and, thus, different molecular vibrational modes (3, 59). In this way FITR 
imaging provides chemical specificity and multidimensional data and has been used for probing 
both diagnostic and prognostic questions related to prostate (3, 60), colon (61, 62) and breast 
cancer (63, 64). However, compared to conventional light microscopy FTIR has lower resolution 
and throughput. In addition, it faces challenges in terms of compatibility with the current 
diagnostic pipeline: both sample preparation and instrument optics vary significantly from those 
used in conventional microscopy. A separate dedicated scanner would need to be deployed if FTIR 
based disease markers are needed as a complement to traditional histopathology. 
 RS imaging measures the frequency shift caused by inelastic light scattering due to  unique 
molecular vibrational and rotational modes within different tissue components (65). Like FTIR it 
has the advantage of providing multidimensional spectral information with chemical specificity. 
Quantitative histopathology using RS imaging has been used for many studies including breast 
(66, 67) and bladder cancer diagnosis (68) as well as investigation of esophageal dysplasia (69). 
However, like FITR, RS imaging is slower than standard bright-field imaging and requires a 
specialized tissue scanner as well as different specimen preparation. 
 SHGM generates contrast in the tissue image by measuring light emitted by non-linearly 
active, non-centrosymmetric materials such as collagen. In these materials, two lower energy 
photons are up-converted to a single photon at twice the incident light frequency (70). In this way 
SHGM provides specificity to collagen in tissue, generating high contrast images that map out the 
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extracellular matrix organization. It has been used for tumor microenvironment investigations of 
breast (5, 71), pancreatic (72) and ovarian cancers (73). In addition to its specificity to collagen, 
SHGM also has the advantage that a standard H&E stained histology can be used as the sample. 
However, SHGM has lower throughput than conventional bright-field microscopy and would, 
once again, require a separate scanner/instrument if it were to be deployed as a histopathology tool 
in the clinic. In addition, since contrast in SHGM is generated only in non-cellular structures, the 
tumor edge cannot be discerned from the SHGM image and other modalities (such as bright-field 
H&E images) need to be combined with it in order to answer clinical questions.  
 In contrast with these methodologies, QPI is not as specific since contrast is generated in 
all structures that have a refractive index difference from their surroundings (27). However, QPI 
provides similar resolution and speed as standard histopathology and, especially in the case of 
SLIM, can be added-on as a functionality to microscopes already in existence in pathology labs. 
Thus far, the key barrier to clinical translation in QPI has been the need for an unstained tissue 
sample for histopathological analysis. This need poses additional sample preparation requirements 
in a clinic - if a pathologist needs QPI markers in addition to H&E based markers, they need to 
prepare a separate sample for QPI. It is, therefore, one of the aims of this thesis to demonstrate that 
QPI can also be performed on standard H&E stained histology to provide both phase maps and 
bright-field images in a single scan (Chapter 6). 
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CHAPTER 3: Breast cancer diagnosis using QPI – Qualitative Assessment 
3.1 Abstract 
 As discussed earlier, the standard practice in histopathology of breast cancers is to examine 
an H&E stained tissue biopsy under a microscope to diagnose whether a lesion is benign or 
malignant. This determination is made based on a manual, qualitative inspection making it subject 
to investigator bias and resulting in low throughput. Hence, a quantitative, label-free and high 
throughput diagnosis method is highly desirable. We present in this chapter preliminary results 
showing the potential of QPI for breast cancer screening and help with differential diagnosis. We 
generated phase maps of unstained breast tissue biopsies using SLIM. As a first step towards 
quantitative diagnosis based on SLIM, we carried out a qualitative evaluation of our label-free 
images. These images were shown to two pathologists who classified each case as either benign 
or malignant. This diagnosis was then compared against the diagnosis of the two pathologists on 
corresponding H&E stained tissue images and the number of agreements were counted. The 
agreement between SLIM and H&E based diagnosis was 88% for the first pathologist and 87% 
for the second. Our results demonstrate the potential and promise of SLIM for quantitative, label-
free and high throughput diagnosis. 
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3.2 Motivation and overview  
 As described in Chapters 1 and 2, quantitative histopathology of the breast is key to 
improving patient health outcomes as it provides an objective and potentially automatable basis 
for diagnosing disease. Thus, a QPI based diagnosis method can potentially improve on the current 
gold-standard of microscopic examination of stained tissue in terms of objectivity and throughput 
and provide additional information for difficult cases. In this chapter we present preliminary results 
that show the potential of a SLIM based technique for diagnosis of breast cancers. Specifically, 
the resolution and contrast of SLIM phase images for diagnostic purposes were evaluated 
qualitatively by two board certified pathologists. As outlined in detail in the following sections, 
using the standard H&E staining based diagnosis protocol as a benchmark, the success of the 
pathologists in carrying out diagnosis on SLIM images was measured. Our results provide an 
indication of the signal to noise ratio available to us for subsequent quantitative analyses for 
carrying out diagnosis based on the relative phase values of various tissue components. The work 
presented in this chapter is based on the work published in ref. (51). 
3.3 Experimental procedures 
3.3.1 TMA 
 The samples consisted of a TMA of cores constructed from breast tissue biopsies of 400 
different patients. Each biopsy was formalin fixed and paraffin embedded before sectioning it into 
slices of 4 μm thickness each, using a microtome. Two parallel, adjacent sections were selected 
from each biopsy and one of these sections was stained using H&E, leaving the other one 
unstained. Cores were then constructed for both the stained and unstained tissue and these were 
mounted on separate slides after de-paraffinization, using xylene as the mounting medium. The 
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stained samples were imaged used a bright field microscope and their images served as a reference 
for evaluating diagnosis on the unstained samples using SLIM. The slides were obtained from our 
collaborating pathologist at the University of Illinois at Chicago (UIC) Dr. Andre Balla. The 
procedures used in this study for conducting experiments using human subjects were approved by 
the Institute Review Board (IRB) at the University of Illinois at Urbana Champaign (IRB Protocol 
Number 13900). 
3.3.2 Slide scanning and mosaicking 
 The TMA was imaged using our SLIM imaging system (Figure 2.2), equipped with a 
40x/0.75 NA phase contrast objective. A slide scanning software, developed in-house in Visual 
C++, was used to obtain the raw images for the entire microscope slide (scanning area approx.  20 
mm x 45 mm) at high throughput (approx. 2 hrs per slide).  
 The phase maps were extracted from the acquired intensity images using a MATLAB-
based code. A C++-based code was used for stitching the mosaic for the entire slide and 
segmenting out each individual core for subsequent processing and analysis. As shown in Figure 
3.1, our processing allows the visualization of the entire TMA from the slide scale to the sub-
cellular scale within each core. As illustrated in Figure 3.1 (c), our label-free SLIM images clearly 
delineate the epithelial stromal boundary allowing for assessment of tumor malignancy.  
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Figure 3.1 (a) The SLIM image of an entire TMA slide (20 mm x 45 mm) scanned and stitched 
using software developed in-house. (b) Label-free SLIM image of a single TMA core delineating 
the boundary between the tumor and its extracellular environment. (c) Magnified image of region 
indicated in (b) clearly showing tumor cell nuclei and collagen fibers, specific to epithelial and 
stromal regions. 
 
 
3.3.3 Pathologist training procedure 
 In order to assess the diagnostic capabilities of our SLIM imaging modality, we asked two 
board certified pathologists to evaluate our SLIM images. For this preliminary study, we selected 
109 cores for evaluation and stacks of both SLIM and corresponding H&E images for these cores 
were assembled in ImageJ. Since pathologists are generally trained to recognize morphological 
features in H&E stained tissue, we performed a training step before the actual test. In this training 
step, out of the total cohort of 109 cores, 10 benign and 10 malignant cores (classified as such by 
a third board certified pathologist a priori) were chosen and their SLIM and H&E images were 
shown side by side to each pathologist. By comparing the SLIM and H&E images for each core, 
the pathologists were able to learn how to interpret the tissue morphological details from SLIM 
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phase maps. The total training time for each pathologist ranged from 10 – 15 minutes, 
approximately.  
 Figure 3.2 compares and contrasts how different tissue components are resolved in SLIM 
and H&E stained tissue images. Due to the fact that our system uses phase contrast illumination, 
SLIM images inherit some of the halo artifact that is characteristic of phase contrast images. This 
effect is due to the fact that some of the high spatial frequency components pass through the low 
spatial frequency or D.C region (ring) in the Fourier plane [Fig. 2.2 (c)]. As a result, negative phase 
values are observed at sharp edges in the SLIM phase images. Since the study presented here is 
based on visual interpretation of SLIM images by pathologists, the halo artifact does not affect our 
results because, as illustrated in Figure 3.2, the tissue morphology is not obscured by the presence 
of the halo artifact. Typically, for quantitative studies based on measuring physical parameters, we 
use halo removal algorithms developed in house to recover halo free quantitative phase images 
(74, 75) 
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Figure 3.2 Comparison between H&E stained bright field microscopy (top row) and SLIM 
(bottom row) images in their respective abilities to resolve tissue morphology for (a) benign and 
(b) malignant cases. The H&E images were obtained from stained sections that were adjacent to 
the unstained sections used for SLIM imaging. Color bars are in radians. 
 
3.3.4 Pathologist diagnosis using SLIM 
 After the completion of the training step, at the testing stage, each pathologist was first 
shown the stack of SLIM images for all of the 109 cores chosen. The pathologist classified each 
core as either benign or malignant. The process was repeated for the stack of H&E images for the 
same 109 cores. Using each pathologist’s diagnosis on the H&E stained cores as the gold standard, 
the success of diagnosis using SLIM images was measured by counting the number of agreements 
between SLIM and H&E based diagnoses. The entire exercise is schematically depicted in Figure 
3.3.  
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Figure 3.3 Diagnosis using SLIM images by pathologists and comparison with H&E based 
diagnosis. (a) The training step was performed prior to the experiment. For 20 cores out of the 
cohort of 109 cores in total, both SLIM and H&E images were shown side by side to each 
pathologist, training the pathologist to interpret morphology from SLIM images by comparing 
features with corresponding H&E images. (b) For the entire 109 core cohort, each pathologist 
classified a core as either benign or malignant by looking at their SLIM images. The process was 
repeated for H&E images and number of agreements between the two diagnoses were counted 
for each pathologist. 
 
3.4 Results 
 The results of the core classification carried out by the two pathologists on both SLIM and 
H&E images are summarized in Figure 3.4. As shown in Figures 3.4 (c) and (d), the success rate 
of diagnosis on SLIM images (considering diagnosis on H&E as the gold standard) for pathologist 
1 was 88% and that for pathologist 2 was 87%. As shown Figures 3.4 (a) and (b), the agreement 
between the two pathologists when rating SLIM images stood at 83% whereas the same for H&E 
images was much higher at 98%. The lower agreement between the two pathologists on SLIM 
images is not surprising when one takes into account the fact that, as part of their professional 
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training, pathologists are trained to interpret images of H&E stained tissue for a number of years 
whereas, for this experiment, the training time for SLIM images was only a few minutes. We 
expect the agreement between the diagnoses of the two pathologists on SLIM images to increase 
significantly with longer training in interpreting SLIM images.  
Figure 3.4 Confusion matrices showing results of qualitative diagnosis carried out by two 
pathologists on both SLIM and H&E stained tissue images for 109 cores. (a) Pathologist 
agreement on SLIM images. (b) Pathologist agreement on H&E images. (c) and (d) Agreement 
between ratings on SLIM and H&E images for each pathologist. 
 
3.5 Summary and Conclusion 
 The preliminary results discussed in this chapter show the capability of our label-free 
imaging modality of resolving morphological features relevant for diagnosis of breast cancer. 
While this qualitative analysis is promising, the actual research aim in this thesis is to leverage the 
tissue physical properties extracted by SLIM for quantitative analysis. This is addressed in Chapter 
4, for which the results of chapter 3 provide motivation - all that remains is to come up with the 
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appropriate feature extraction and supervised learning method in order to detect quantitative 
markers of malignancy automatically. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 
 
CHAPTER 4: Breast cancer diagnosis using QPI – Quantitative Assessment 
 
4.1 Abstract 
 
 Building on the evidence shown in the last chapter that SLIM images resolve 
morphological markers of malignancy we present in this chapter a quantitative method for label-
free breast tissue evaluation using SLIM. We rely on scattering, geometric and texture-based 
features, extracted from OPD maps of breast tissue. We demonstrated our method by imaging a 
TMA consisting of 68 different subjects - 34 with malignant and 34 with benign tissues. Three-
fold cross validation results showed a sensitivity of 94% and specificity of 85% for detecting 
cancer. Our disease signatures represent intrinsic physical attributes of the sample, independent of 
staining quality, facilitating classification through machine learning packages since our images do 
not vary from scan to scan or instrument to instrument.  
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4.2 Motivation and Overview 
 To date, a majority of quantitative image analyses on breast tissue biopsies have relied on 
color images of stained tissue. Image classification in these cases has involved computing a wide 
range of histological features including geometric features (76, 77), texture-related features (78, 
79) and radiometric features (78) (80, 81) [see (19) for a review of methods]. However, the feature 
extraction process relies heavily on tissue staining which can vary from sample to sample and 
instrument to instrument, affecting the robustness of the classifier (82). We present in this chapter 
a label-free QPI based approach which makes classification through machine learning easier since 
the instrument does not require calibration for inconsistency in pixel values due to variations in 
staining, tissue changes caused by harsh solvents etc. These advantages of QPI have already been 
leveraged to develop supervised learning methods for classifying erythrocytes infected with 
Plasmodium falciparum (83) and non-activated lymphocytes (84).  
 We demonstrate the quantitative analysis capabilities of our tissue evaluation system by 
imaging a TMA comprising 68 different cases (34 benign and 34 malignant). For each epithelial 
region (ER) within a tissue core, we extracted scattering, geometric, and texture-related markers 
of tissue malignancy from the SLIM maps (see Section 4.3 Materials and Methods). A linear-
discriminant analysis (LDA) classifier was trained to separate benign cases from malignant cases 
and three-fold cross validation was performed to measure the classification accuracy of the learned 
model (85, 86). Using validation by the Receiver Operating Characteristic (ROC) curve analysis, 
our results revealed a sensitivity of 94% and specificity of 85%. Our results are the first 
demonstration, to our knowledge, of using OPD based tissue markers for detecting malignancy in 
breast tissue, label-free.  The work presented in this chapter is based on the work published in ref. 
(87). 
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4.3 Materials and Methods 
4.3.1 SLIM optical system 
 We used the SLIM imaging system for this study, the working principle of which was 
described earlier in Section 2.3. Throughout our experiments, a 40x/0.75 NA phase contrast 
objective was used for imaging. At this sampling rate (6.2 pixels/ m ), the typical time for 
imaging a single tissue core (1 mm2 area) was approximately 12 sec. 
4.3.2 TMA 
 The TMA used for our study was purchased from US Biomax Inc. (Serial # BR-1002) with 
diagnosis for each case provided by the manufacturer through examination by a board certified 
pathologist. The TMA was obtained with all human subject information de-identified. Neither the 
authors of this work nor their institutions were involved in the collection of tissue. The TMA 
consisted of cores 1 mm in diameter and a section thickness of 5 µm. Standard FFPE histological 
preparation was used for each tissue block before extraction of cores. A xylene based mounting 
medium was used during cover-slipping. 
 The TMA consisted of 36 cases of infiltrating ductal carcinoma (IDC), 36 cases of tumor 
adjacent normal tissue and 10 cases of normal breast tissue derived from autopsy procedures (one 
core per case). Three of the tumor adjacent normal cores were obtained from the IDC cohort. The 
TMA was designed to mix approximately equal numbers of histologically normal and 
histologically invasive carcinoma cases. The post-mortem interval for autopsy cases was less than 
6 hours and after assembly the TMA was inspected for quality control and diagnosis by the 
manufacturer through review by a board certified pathologist. For final analysis we selected 34 
cores diagnosed as malignant and 34 cores diagnosed as normal (within which 28 were tumor 
adjacent normal and 6 were normal). Each of these final cores were selected based on whether the 
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core was intact and whether any epithelial tissue was present in the core (cores containing only 
stromal tissue were excluded).  
 A SLIM image of the whole TMA slide is illustrated in Fig. 2.2 (c). Figs. 2.2 (d) and (e) 
show, respectively, the phase map and the H&E stained tissue bright field image (henceforth 
referred to as ‘H&E image’) of one core. For obtaining a mosaic of the TMA, we used a C++ based 
stitching code, developed in-house (50). After staining the same tissue slide using standard 
protocols (13), H&E images of the TMA were acquired using a bright-field microscope (Carl 
Zeiss, Axio Observer Z1) outfitted with a color camera (Carl Zeiss, Axiocam MRC). The H&E 
images were used for qualitative evaluation only, to assist with annotation of epithelial regions in 
tissue, discussed below.  
4.3.3 Annotation of epithelium in tissue images 
 Each gland or continuous ER within each core was manually annotated using the region of 
interest (ROI) tool of ImageJ to allow feature extraction for each ER. A consistent criterion for 
annotation was used where groups of epithelial cells bounded by stroma on all sides were 
considered a single ER. Other tissue components within epithelium (such as lumen etc.) were 
considered part of the ER if bounded on all sides by epithelial cells. ERs from cores in the cancer 
cohort were labelled as malignant while those from cores in the normal cohort were labelled as 
benign. 
4.3.4 Extraction of geometric and scattering features 
 Malignant transformation in breast tissue affects the size, shape and density of epithelial 
cells as well as the shape and organization of epithelial tissue. As a result, both the geometry and 
scattering properties of an ER (tumor) are affected. We used ER perimeter curvature C , as well 
as the mean scattering length sl  as part of the feature set used for separating benign and malignant 
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tissue. The parameter extraction process is illustrated in Fig. 4.1 and a detailed description for each 
is provided below. 
 The extrinsic curvature C  of a two-dimensional plane curve ( , )x y , that is parametrized 
by Cartesian coordinates ( )x s  and ( )y s  with parameter s , is given by the expression (88) 
 
( )
3
2 2 2
| ' '' ' '' |
( )
' '
x y y x
C s
x y
−
=
+
,  (4.1) 
where the 'x , 'y  and ''x , ''y  refer to the first and second derivatives in s  , respectively. In the 
above parametrization, s refers to each pixel comprising the curve ( , )x y , having coordinates ( )x s  
and ( )y s . This curvature can be interpreted as the magnitude of the rate of change of a vector 
tangent to ( , )x y . We computed C  for the perimeter ( , )x y  of each annotated ER by using an 
open source MATLAB code (89). The code approximates ( , )x y  as a polygon before computing 
C  for each point defining the ER perimeter, as described in Eq. (4.1). To speed up computation, 
the image of each core was first down-sampled from the raw image size of 8000 x 8000 to 2048 x 
2048 pixels. The sampling rate in the down-sampled image was 1.59 pixels/ m  and a bi-cubic 
interpolation technique was used for down-sampling. The perimeter ( , )x y was then further down-
sampled by a factor 20 (every 20th pixel was analyzed) before computing ( )C s  in order to remove 
any pixel level errors due to manual annotation. The median ER curvature C  was then used as a 
feature for separating benign and malignant cases. Figs. 4.1 (c) and (d) illustrate C  for 
representative benign and malignant ERs.  
 The scattering mean free path sl , is a bulk scattering parameter that defines the length scale 
over which a single scattering event occurs on average. Assuming that the tissue slice captures the 
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refractive index spatial fluctuation statistics, i.e., assuming statistical homogeneity, sl  can be 
computed through the scattering-phase theorem using the expression (57) 
 
var[ ( , )]
s
L
l
x y
= ,  (4.2) 
where ( , )x y  is the SLIM phase image, L  is the tissue section thickness and the operator  var .  
computes the spatial variance over a region. The sl  parameter has been used in the past for 
discriminating between benign and malignant prostate tissue (52). We first computed the image 
( , )sl x y  from the phase image ( , )x y  (8000 x 8000 pixels) using a variance filter kernel size of 149 
x 149 pixels, which equals the approximate diameter of 3 epithelial cells. The feature sl  was 
then computed by calculating the median of ( , )sl x y  over the ER area. This computation is 
illustrated in Figs. 4.1 (e) and (f). 
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Figure 4.1 Computing the geometric feature C  and scattering feature sl over each annotated 
ER. (a) and (b) H&E images of benign and malignant ERs, respectively. (c) and (d) SLIM 
images of the same benign and malignant ERs, respectively, illustrating ER curvature C . The 
median over ER C is used as the geometric feature for classification. (e) and (f) ( , )sl x y for 
benign and malignant ERs, respectively. The median over ER sl is used as the scattering 
feature for classification. 
 
4.3.5 Extraction of texture-related features 
 Benign and malignant epithelial tissues differ not only in cell morphology but also in the 
organization of their components, leading to different textures. Texture-related features have been 
used in the past for solving different classification problems in histopathology of cancers (19, 25). 
Our feature extraction follows the work done by Varma et al. (90) for classifying different 
materials based on their texture. The approach is illustrated in Fig. 4.2. Each TMA core phase 
image was first down sampled to 2048 x 2048 pixels from 8000 x 8000 pixels [Fig. 4.2 (a)]. A bi-
cubic interpolation was used for down-sampling and the sampling rate in the down-sampled image 
was 1.59 pixels/ m . The down-sampled core image was then filtered through a convolution with 
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the Leung-Malik (LM) filter bank [Fig. 4.2 (b)]. This filter bank consists of gradient filters (both 
odd and even) at different orientations and spatial scales (91) . In total, 58 different filters were 
used, generating a 58-dimensional response vector for each pixel in the core phase image [Fig. 4.2 
(c)]. The response vectors from ERs within each core were then randomly sampled (10000 vectors 
per core) to generate a smaller dataset for further processing. K-means clustering was then 
performed on the response vectors (number of clusters, K = 50) sampled from all cores within each 
training set (see Results and Discussion) and the computed cluster centroids were referred to as 
‘textons’ (90, 91).  K = 50 was chosen iteratively by repeatedly measuring the cross-validation 
AUC (see Results and Discussion, Section 4.4) and determining the number of clusters required 
to maximize it (to account for both overfitting and separation accuracy). Since each pixel in each 
core belongs to a texton, for each pixel the histogram of textons was generated for its vicinity 
(window size 60 x 60 pixels) and was used to characterize the local texture in that neighborhood. 
This way, a 50 dimensional feature vector T  was generated to characterize texture in a pixel’s 
neighborhood. An open source MATLAB code was used for generating the LM filter bank for this 
work (92).  
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Figure 4.2 Algorithm for computing the texture in a pixel’s neighborhood. (a)-(c) Generating the 
response of each pixel to an LM filter bank. (d) K-means clustering of response vectors, 
generated from all cores in the training set, in order to find 50 cluster centroids or textons. (e) 
Histogram of textons, within a pixel’s neighborhood, comprise the texture-related feature vector 
T for each pixel. 
 
 
4.3.6 Classifier training and validation 
 Since our work involves classifying each tumor within a tissue core as benign or malignant, 
a feature vector for each ER was next generated by concatenating geometric, scattering and 
texture-related features. This procedure is illustrated in Fig. 4.3. After pixel-wise computation of 
ER curvature C , scattering length sl  and texture vector T , the median of each feature was 
computed over each ER in a core and a combined 52 dimension feature vector was generated for 
training. For each ER, this feature vector was then used as a predictor for training an LDA classifier 
[Fig. 4.3 (a)]. Class labels, either benign or malignant, were used as the ground-truth for each ER 
during the training process. All ERs within cores deemed cancerous by the pathologist were 
labelled malignant and all ERs within cores deemed normal were labelled benign. 
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 The feature extraction for validation purposes, illustrated in Fig. 4.3 (b), followed a nearly 
identical procedure to that used during training. The only difference was that, instead of finding 
new textons (cluster centroids) for validation data, the texture feature vector T was computed by 
using the same textons as determined during training. As in training, a 52 dimensional feature 
vector was input to the LDA classifier which then used the model learned during training to 
generate a likelihood score for an ER being benign or malignant. Finally, the mean of the likelihood 
scores of all ERs within a core was computed and used as the likelihood score of a core being 
benign or malignant. These scores were then used to generate an ROC curve to select an operating 
point for separating benign and malignant cases (see Results and Discussion). For an annotated 
test core the total time required by our algorithm to generate a core likelihood score was 
approximately 2 minutes. This is in the absence of any parallelization of the computation through 
graphics processing unit (GPU) implementation which can significantly boost the computational 
throughput.  
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Figure 4.3 (a) Training and (b) Validation procedure for classifying ERs as benign or malignant. 
 
 
4.4 Results and Discussion 
 
 The classification results of our analysis are summarized in Fig. 4.4. In order to  evaluate 
the accuracy of our method, we performed three-fold cross-validation (93) as illustrated in Fig. 4.4 
(a). The total number of cases were divided into three (nearly) equal groups. In each trial, two 
groups were used for training while the remaining one was used for validation. Thus, three 
validation trials were performed, each time selecting a different validation/training set 
combination.  
 Figure 4.4 (b) illustrates the separation between benign and malignant ER feature vectors 
in one training set. In order to illustrate the data separation in 3 dimensions, we use principal 
component analysis (PCA) and represent the 50-dimensional feature vector T  through its first 
principal component PC1 T . The training space shows that scattering feature sl  has on average 
higher values for malignant ERs than for benign ERs. This finding is compatible with typical ER 
morphology in breast tissue since benign ERs are well differentiated, consisting of a number of 
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different structures including epithelial cells, lumen and myoepithelial cells (94). This 
heterogeneity of structure results in short mean scattering lengths as explained by a large variance 
in Eq. (4.2). Malignant ERs on the other hand consist of a monoclonal proliferation of cells, 
sometimes even showing sheets of poorly differentiated epithelial cells, resulting in smaller 
variance and larger sl  values (94).  These phenomena can also be observed in the examples given 
in Figs. 4.1 (e) and (f). In previous investigations on prostate cancer, it was shown that sl  has a 
lower value in malignant tissue than in benign tissue (52). That analysis, however, was carried out 
on larger areas of tissue where cellular organization can be different from the epithelial only 
regions we are studying in this work (52).  
 The median ER curvature C , on the other hand, generally has higher values for benign 
ERs than for malignant ERs. This is a result of the fact that the edge of a benign ER is constrained 
to follow a round or elliptical shape due to tubule formation [Figs. 4.1 (a) and (c)] (94). When 
malignant transformation occurs, this constraint is broken and the ER edge is more irregular. At 
the spatial scale of investigation we have used here (approx. 13 m ), the perimeter of the malignant 
ER is less rapidly varying, on average, than that of a benign ER. This geometric feature is similar 
to the previous measurement of the ER perimeter fractal dimension that has been used for 
histopathology (19, 76).  
 Fig. 4.4 (c) shows the separation between benign and malignant ERs in the validation 
feature space, where, qualitatively, the same separation trend is seen as in training. We show the 
results of only one of the three validation trials that were carried out. As described in Materials 
and Methods, the ER likelihood scores, generated by the classifier during validation, were 
averaged over each ER in order to obtain core-wise or case-wise scores.  The standard deviation 
of ER likelihood scores, within each core, had a mean value of 0.18, a median value of 0.19 and a 
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maximum value of 0.41 for the benign dataset (i.e across 34 cores). The same for the malignant 
dataset (again across 34 cores) were 0.17, 0.17 and 0.37, respectively. This indicates that the 
malignant cores consisted primarily (if not entirely) of malignant ERs since the variance of ER 
likelihood scores over them was similar to that over benign cores, which consisted entirely of 
benign ERs. In addition, while we treated all ERs within cancerous cores as malignant during 
training, removing any benign tissue from malignant cores, during classifier training, is likely to 
improve our accuracy rather than worsen it. 
 The core-wise likelihood scores from the 3 trials were then pooled together to generate the 
ROC curve illustrated in Figure 4.4 (d) (95). Our results indicate an area under the curve (AUC) 
of 0.91. The optimum operating point for classification was determined by using the standard 
method of assigning equal weight to the cost of misclassifying positives and the cost of 
misclassifying negatives (96). This resulted in a sensitivity of 0.94 and specificity of 0.85 for the 
three-fold cross validation. When the same analysis was repeated by using the median rather than 
the mean of the ER scores over each core (to get a case-wise score), it resulted in an AUC of 0.91 
and sensitivity and specificity of 0.94 and 0.82, respectively. While we use the standard method 
for determining the operating point here (which assigns equal cost to false negatives and false 
positives) in principle any operating point along the ROC curve can be chosen depending on the 
application (e.g 0.97 sensitivity and 0.77 specificity). Having said that, the higher sensitivity of 
0.94 is useful since it results in a smaller number of false negatives than false positives. Minimizing 
false negatives is more important than minimizing false positives since the latter only result in 
further investigations of the patient whereas the former constitute a missed diagnosis. A sensitive 
method is also useful in situations where a small biopsy specimen is available and detection of 
small amounts of malignant tissue visually is a challenge for the pathologist.  
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 Our results are significant because they are the first illustration of tissue OPD derived 
features being used to detect intrinsic markers of malignancy in breast tissue, using supervised 
learning. While previous works employing image analysis and supervised learning for detecting 
cancerous regions in H&E-stained tissue images have demonstrated good classifications AUCs 
(greater than 0.90) (19, 76, 97, 98), accounting for stain variation through normalization remains 
a challenge (82) due to a lack of universal agreement on the correct normalization method (19). 
Our label-free results, thus, eliminate an important factor affecting consistency of results between 
different samples and instruments whilst maintaining high sensitivity and specificity.    
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Figure 4.4 (a) Three-fold cross-validation procedure for evaluating classification accuracy. (b) 
Separation of benign and malignant ER feature vectors during training in 1 of 3 validation trials. 
(c) Separation of benign and malignant ER feature vectors during validation in 1 of 3 validation 
trials. (d) ROC curve for the 3 validation trials resulting in a sensitivity of 0.94 and specificity of 
0.85 at the optimum operating point. 
 
 
4.5 Summary and Conclusions 
 In summary, we presented in this chapter a new method for quantitative evaluation of tissue 
biopsies obtained from patients under investigation for breast cancer. Since our method relies on 
measurement of OPD maps, an intrinsic property of tissue, the basis for classification is objective 
and not subject to inter-observer variation. In the past much of quantitative histopathology has 
relied on analysis of stained tissue. However, stain variability continues to remain a grand 
challenge in applying computer algorithms across multiple H&E stained specimens. This fact is 
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well documented in the literature, as follows. In ref. (99), it is stated that: “On the technical side, 
one of the main challenges in the computational interpretation of digital slide images has to do 
with color variations in the tissue induced by differences in slide preparation, staining, and even 
whole slide scanners. Clearly decision support algorithms that aim to work on digital pathology 
images will have to contend with and be resilient to these variations.” In ref. (20) the authors state  
that “One of the major difficulties in breast cancer histopathology image analysis, particularly of 
H&E stained sections, is appearance variability.” As a final example, ref. (100) states “It is clear 
that an integral part of digital pathology that has yet to be resolved is colour standardization; in 
order to do so, further work is needed focusing upon fine-tuning colour calibration methods in 
relation to the effect on diagnosis.”  
Although OPD depends on tissue slice thickness which can vary slightly from section to 
section, previous studies on colorectal and prostate cancer, using SLIM, have indicated that 
variations in OPD due to cutting errors are insignificant (50, 101). These studies looked at the 
variation of median phase values and anisotropy in scattering between tissue slices having the 
same nominal thickness and reported insignificant differences. Despite this preliminary evidence, 
future studies where variation in our feature set is explicitly tested against tissue slice thickness 
variation are required. While in this work we have performed manual segmentation of epithelium, 
the automation of the entire process (including segmentation) is feasible and subject to future 
efforts.   
 While our cross-validation results show promising sensitivity and specificity, a number of 
further studies are proposed before clinical adoption of our method. First, our analysis needs to be 
further tested with separate training and testing tests, the latter being obtained from an independent 
laboratory and remaining unused during model development. Second, our feature set needs to be 
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applied to more clinically difficult cases since making frank benign versus frank malignant 
diagnoses is not currently a serious challenge for pathologists. However, our results demonstrate 
an important and necessary first step and we propose to apply our feature set, in future studies, to 
more challenging cases such as stratification of benign lesions as well as distinguishing ductal 
carcinoma in situ (DCIS) from benign atypical hyperplasia (BAH) (102, 103). Third, while we 
have applied our diagnosis method to cases of IDC, the most widely prevalent form of breast 
cancer, the applicability of the model to other histological sub-types (such as infiltrating lobular 
carcinoma) also needs to be explored. 
 While other label-free diagnosis methods have been proposed for these types of 
investigations, they affect the standard diagnostic pipeline in terms of either speed, resolution or 
compatibility with established workflow. SLIM, on the other hand, requires minimal changes to a 
conventional microscopic optical train due to its modular design. Even though in this study a 
research grade microscope was coupled to the SLIM module, in principle SLIM can be used with 
any phase contrast microscope. Furthermore, the SLIM instrument is less expensive than most 
commercial tissue scanners. Our results, although preliminary, are an important stepping stone 
towards extracting reliable novel markers that can provide pathologists adjunct information to 
H&E based markers for assessing difficult cases. In addition, computational pathology tools such 
as ours can help pathologists where the biopsy specimen is small and highly sensitive detection is 
desired. 
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CHAPTER 5: Quantifying collagen fiber orientation in breast tissue using QPI 
 
5.1 Abstract  
 Tumor progression in breast cancer is significantly influenced by its interaction with the 
surrounding stromal tissue. Specifically, the composition, orientation and alignment of collagen 
fibers in tumor-adjacent stroma affects tumor growth and metastasis. Most of the work done on 
measuring this prognostic marker has involved imaging of collagen fibers using SHGM, which 
provides label-free specificity. Here we show that SLIM is able to provide information on 
collagen-fiber orientation that is comparable to that provided by SHGM. Due to its wide-field 
geometry, the throughput of the SLIM system is much higher than that of SHGM and, because of 
the linear imaging, the equipment is simpler and significantly less expensive. Our results indicate 
that SLIM images can be used to extract important prognostic information from collagen fibers in 
breast tissue, potentially providing a convenient high throughput clinical tool for assessing patient 
prognosis. 
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5.2 Motivation and Overview 
 As explained earlier in Chapter 1, prognostic markers provide clinicians with important 
information about disease aggressiveness, cancer sub-type and expected patient outcomes (4). This 
allows these clinicians to make treatment decisions that best suit a patient’s disease state and avoid 
over-treatment (6, 24). Current markers, such as histological grade, hormone receptor status, tumor 
size etc., while useful for most patients, do not accurately predict outcomes for all patients. Thus, 
there is a need to expand on the current prognostic markers to account for biological variation 
among individuals (5, 6). 
 The role of adjacent stroma in mediating breast tumor initiation, progression, and invasion 
to surrounding tissue has been extensively discussed over the years (104-108). Tumor invasion 
into surrounding healthy tissue involves breaking down of the basement membrane and a 
desmoplastic response in the stroma. This response involves an increase in density of the 
extracellular matrix (ECM), marked by increased deposition of collagen, as well as recruitment of 
stromal cells (e.g. fibroblasts and inflammatory cells) to facilitate tumor growth (5, 105, 106). 
Using both mouse and in vitro models of mammary tissue, studies have also concluded that tumor 
progression is marked by re-alignment and re-orientation of collagen fibers (5, 109-111). For 
example, Conklin et al.  showed that the Tumor Adjacent Collagen Signature 3 (TACS3) correlates 
with lower disease-free and disease-specific survival in breast cancer patients (5, 112). TACS3 
refers to the histological marker involving aligned collagen fibers that are oriented perpendicularly 
to the tumor edge (5). 
 As described in Chapter 2, SHGM has emerged as a powerful technique for imaging 
collagen fibers in breast cancer adjacent stroma with sub-cellular resolution (113). SHGM 
measurement of the prognostic signature TACS3 was reported in ref. (5). Ambekar et al.  used 
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Fourier analysis on SHGM images to show that the collagen fibers in breast biopsies are more 
aligned in malignant  vs. pre-malignant and benign tissue (71). Riching et al.  used SHGM to image 
3D collagen gels to elucidate specific epithelial cell-fiber interactions that are responsible for 
enhancing tumor progression along aligned fibers in breast tissue (114). Other researchers have 
used image segmentation and machine learning tools to extract prognostic information from 
SHGM images of collagen fibers (115, 116).  
 SHGM maps the second-order non-linear susceptibility ( )
2
   associated with non-
centrosymmetric molecules and thus probes fibrillar collagen structures with specificity (113). As 
detailed in Section 5.3, collagen generates a strong second-harmonic signal compared to the 
surrounding cellular structures, resulting in high imaging contrast (117). However, the low contrast 
of other cellular structures in SHGM images means that the tumor boundary is difficult to delineate 
and often other imaging modalities are required (116). Furthermore, since SHGM systems employ 
a laser point-scanning geometry, the imaging throughput is low and whole slide scanning of breast 
cancer tissue sections remains a tedious task.   
 In this chapter, we show that SLIM, in conjunction with basic image segmentation, is able 
to provide information on collagen-fiber orientation and alignment similar to that obtained using 
SHGM. In addition, SLIM generates contrast for epithelial cells as well, which can be used to 
detect tumor boundaries. Furthermore, compared to SHGM, the SLIM images are acquired at 
much higher throughput due to the wide-field geometry. Using both SLIM and SHGM, we imaged 
a TMA of breast biopsy cores consisting of both benign cases and malignant cases at different 
stages of the disease. Using the Fourier analysis method described in Section 5.5 we show that 
both SLIM and SHGM images generate similar histograms of fiber orientation angle.  
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 This chapter is organized as follows. In Section 5.3, we present the theoretical foundation 
for extracting second-order nonlinear response from phase-resolved linear imaging. Section 5.4 
describes the experimental details of the study, and Section 5.5 presents the results. Section 5.6 
summarizes and discusses these results. The work presented in this chapter is based on the work 
published in ref. (118). 
5.3 Theory 
 In this section we explain the theoretical motivation for using SLIM for collagen fiber 
analysis imaging by showing that the signal measured in SLIM is related to that measured in 
SHGM. The source of the signal measured in both modalities is the induced polarization P . To the 
second-order approximation, this can be related to the fundamental (incident) field E  as  
 ( ) ( ) ( ) ( )1 2 2 2 ,   = +P E E  (5.1) 
where ( )
1  is the first-order electric susceptibility, ( )
2  is the second-order nonlinear susceptibility 
and   is the optical frequency of the source (119). 
 The physical quantity measured in SLIM is the spatially-resolved linear response, 
( ) ( ) ( )1 2 20n n = −r  r  with n  being the refractive index of tissue, 0n  the refractive index of the 
immersion medium, and ( ),x y=r . Note that for low refractive index contrast, ( )1  simplifies to 
( ) ( ) ( )1 0 02  .n n n   −  r r   The SLIM signal is the optical path-length map generated by the tissue 
slice 
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( ) ( )0 0n n t =  −  r r         
(1)
0
0
( )
2
t
n


r
      (5.2) 
where 0 2 /  =  is the wavenumber in vacuum, t  the local thickness of tissue, and   the 
wavelength of the illumination (27). 
 The physical quantity measured in SHGM is ( ) ( )2 2  , which relates to the SHG electric 
field ( )2SHG E  via (113, 119-121) 
 ( ) ( ) ( ) ( )22 202  2SHG     E E .                                 (5.3) 
 We can find a relationship between the ( ) ( )2 2    and ( ) ( )1   signals measured by our two 
imaging methods by solving the equation of motion for the anharmonic oscillator describing 
microscopic charge displacement [see, for example, Section 1.4. in ref. (119)]. This leads to the 
expression  
 ( ) ( ) ( )
( ) ( )
( ) ( )
2 2
2
10
1
0
,   22 1
, , .
,   2
n
t A
 
   
  
 
 = =   
 
r
r r
r
                              (5.4) 
In Eq. (5.4), 
2
0
2 3
a m
A
N e
= , where a  is a constant that depends on the mechanical properties of the 
anharmonic oscillator model, N  the volume density of electric dipoles in the medium, 0  is the 
permittivity of free space,  m  the mass of an electron and  e  the elementary charge. Equation (5.4) 
indicates that the second-harmonic response is proportional to the squared of the linear response, 
which is measured directly by SLIM, namely 
 
 ( ) ( ) ( ) ( ) ( )2 1 2, 2 ~ , 2  , .      r r r       (5.5) 
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This relationship can then be used to re-write Eq. (5.1) in the form 
 ( ) ( ) ( ) ( ) ( )1 1 2 2 2  .     = +P E E  (5.6) 
In Eq. (5.6) the linear term generates the SLIM signal and provides contrast in both 
centrosymmetric and non-centrosymmetric structures. The quadratic term accounts for the SHGM 
signal and generates contrast only in non-centrosymmetric structures (119). Since the quadratic 
term has a dependence on ( ),x y , we anticipate that in non-centrosymmetric regions (collagen 
fibers) SLIM and SHGM images provide similar morphological information. However, before a 
comparison between the two can be made, the centrosymmetric information in SLIM (linear 
imaging) needs to be extracted out. In this work, we extract this information out using image 
processing techniques as discussed in the Section 5.5.  
5.4 Materials and Methods 
5.4.1 The SHGM and SLIM imaging systems 
 The optical setups for the two imaging modalities are illustrated in Fig. 5.1. The operating 
principle for the SLIM system was outlined in Section 2.3. While that for SHGM has been detailed 
in previous publications (71, 122), here we briefly describe it. 
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Figure 5.1 (a) Optical setup of the SLIM system, built as a module attached to the output port of 
a commercial phase contrast microscope. The insert shows an H&E image of TMA slide, as well 
as H&E and SLIM images of one of its cores. Scale bar: 200 µm. (b) Optical setup of the SHGM 
system. The insert shows an H&E image of the TMA slide as well as H&E and SHGM images of 
one of its cores. C, condenser. Ob, objective. TL, tube lens. IP, image plane. M, mirror. BS, 
beam splitter. SP, short pass. BP, band pass. SLM, spatial light modulator. 
 
 Figure 5.1 (b) illustrates the SHGM system. A Ti: Sapphire laser was used to produce 70-
fs pulses at an excitation wavelength of 780 nm and a repetition rate of 80 MHz. The beam was 
scanned onto the sample, and focused by a 20x/0.8 NA air-illumination Zeiss condenser. The 
transmitted beam was collected in the forward direction by a 40x/0.9 NA Zeiss objective and then 
passed through two filters. The first filter was a 680 nm short-pass filter (680 nm/SP-25) for 
blocking the laser light, and the second was a 390 nm band-pass filter (390 nm ± 18-25 nm) for 
selecting the second harmonic signal. In contrast to the wide-field CCD detector used in SLIM, 
SHGM uses a single point photodetector. More details regarding this particular SHGM system 
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have already been published in refs. (71) and (122). The acquisition rate for SHGM system was 
7 µ𝑠 per pixel while that for the SLIM system was 0.08 µ𝑠 per pixel. 
 
5.4.2 TMA  
 The breast TMA used in this study was purchased from US Biomax Inc. (Serial # T088b).  
The TMA was received from the manufacturer with all human subject information de-identified. 
Neither the authors of this work nor their institutions were involved in tissue collection. The TMA 
comprised of 24 cores from 6 different cases with 8 benign/normal and 16 malignant cases. The 
malignant cases included cores corresponding to three different stages of breast cancer: IIa, IIb 
and IIIa. The inserts of both Fig. 5.1 (a) and 5.1 (b) show an H&E image of the TMA. Also shown 
are H&E, SLIM and SHGM images of one of the cores in the TMA.  
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Figure 5.2. Morphological comparison between (a) Benign and (b) Malignant cores from 
patients at three different stages of disease as captured by SLIM, SHGM and H&E images. The 
square of the quantitative phase map in SLIM is referred to as SLIM2, and is proportional to 
( )
2
1 
 
. 
 
 Figure 5.2 shows H&E, SLIM and SHG images of 3 benign and 3 malignant cores, each at 
a different disease stage, as indicated. The SLIM images generate uniform contrast across the 
cores, including in cellular structures. SHGM images on the other hand generate contrast only in 
areas where collagen fibers are present. Note that the SHG signal is more sparse in the malignant 
cores versus benign cores due to the higher fraction of epithelial cells in the former, associated 
with tumor invasion into surrounding stroma. Row 2 of Figure 5.2 shows the square of the 
quantitative phase map ( ),x y  (SLIM2), for each core.  
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Figure 5.3. SLIM (a-c), SHGM (g-i) and H&E (j-l) images of both stromal and 
epithelial/stromal mixed tissue in a TMA core. Left-most (a,d,g,j) and right-most (c,f,i,l) 
columns show zoomed-in versions of the regions indicated on the core in the central column 
(b,e,h,k). As is evident from a comparison with the H&E images, the SLIM images show 
contrast in both stromal and epithelial regions where as the SHGM images only generate contrast 
in stromal regions. Segmented SLIM (d-f) images were obtained from the SLIM images by 
numerically removing the cellular structures and preserving the collagen fibers. 
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 Figure 5.3 provides a comparison between morphologies of stromal and epithelial tissue 
within one core, as revealed in H&E, SHGM and SLIM images. As shown in Figs. 5.3 (a) and (g), 
both SLIM and SHGM reveal qualitatively similar stromal structures. The situation is different in 
areas with epithelial tissue where SLIM images [Fig. 5.3 (c)] contain centrosymmetric structures 
such as epithelial cells, which are absent in SHGM images [Fig. 5.3 (i)]. The presence of these 
cellular structures is confirmed by the H&E stain, which shows cell nuclei in purple color [Fig. 5.3 
(l)]. In areas that are a mixture of cells and collagen fibers, quantifying fiber alignment and 
orientation from SLIM images requires segmentation of epithelial cells as discussed in detail in 
the next section. 
5.5 Results 
5.5.1 Decoupling isotropic from anisotropic signals in SLIM images 
 Prior to measuring collagen fiber orientation, the SLIM and SHGM images were registered 
and an image segmentation algorithm was used to remove isotropic structures from SLIM images, 
leaving behind the highly anisotropic collagen fibers. No information from the SHGM data was 
used for the segmentation of SLIM images.  
 To perform image registration, the SLIM images were first down-sampled, from 12000 x 
12000 to 9,216 x 9,216 pixels/core, to match the sampling of the SHGM images. These images 
were then co-registered using ImageJ by selecting control point pairs for each image, and matching 
them using transformation techniques (primarily translation and rotation).  
 The image segmentation algorithm used for removing isotropic cellular structures from 
SLIM images is schematically illustrated in Fig. 5.4.  Specifically, for each core image we first 
computed the response to the LM filter bank comprising gradient filters at 50 different orientations 
(90, 91). Each filter in the bank computed the directional image gradient by using the first 
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derivative of a Gaussian, oriented at 
50
j
 =  where j  = 0, 1, 2 ….. 49, from the horizontal axis in 
the image. The resulting stack of responses represented both the magnitude and direction of the 
local gradient or anisotropy in a pixel’s vicinity for each TMA core. The magnitude of these 
gradients was then normalized by the highest value in the stack and was summed along the stack 
(along the z-axis in Fig. 5.4). The resulting image represented the isotropy map of the tissue with 
higher values representing locally isotropic structures (background and cells) and lower values 
representing locally anisotropic structures (collagen fibers). This isotropy map was then low-pass 
filtered (Gaussian kernel of 15x15 pixels which is slightly larger than one epithelial cell) and the 
Otsu’s thresholding method was used to find the grayscale level separating anisotropic from 
isotropic pixels (123). The Otsu thresholding method dynamically sets the threshold by minimizing 
the intra-class variance and maximizing the inter-class variance under the assumption of a bio-
modal class histogram distribution. Since this method establishes a threshold based on the natural 
separation of isotropic and anisotropic pixels in the data, it can be applied to arbitrary SLIM images 
without prior training. After setting the isotropic pixels to zero we employed another round of low 
pass filtering (Gaussian kernel, 5x5 pixels) followed by thresholding to remove any remaining 
background pixels and obtain the label map. During this process, the maximum gradient along z 
for each pixel was also used for detecting the remaining background pixels and marking them for 
removal. The final segmentation map was then computed by using the label map as a mask. The 
segmentation algorithm was coded in MATLAB and a pre-published LM filter generator was used 
for the purpose (92). 
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Figure 5.4 The segmentation algorithm for removing isotropic structures from SLIM phase 
images. (a) SLIM phase map before segmentation (color bar in radians). (b) Response to LM 
filter bank. (c) Normalized isotropy map. (d) Binary label map. (e) Segmented SLIM image 
(color bar in radians). (f) and (g) represent zoomed-in portions of the SLIM and Segmented 
SLIM images respectively, showing an epithelial stromal boundary. The segmentation algorithm 
removes isotropic structures and preserves anisotropic signals associated with collagen fibers. 
 
 
 As apparent from comparing the SLIM and segmented SLIM images in Figs. 5.4 (f) and 
5.4 (g), the algorithm leads to over-segmentation, and sometimes collagen fibers that are isotropic 
at length scales equal to or smaller than the size of one epithelial cell are segmented out. In some 
cases, the segmentation algorithm may break up thin or twisting fibers. As shown in Section 5.4 
(c), these imperfections in segmentation are subdominant, and the local collagen orientation 
remains similar between SLIM and SHGM images. Furthermore, as demonstrated in refs. (5, 121, 
124), biomarkers for prognosis are based on average orientation of collagen over spatial scales that 
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are longer than those at which segmentation errors occur in our images. Thus, for the relevant 
clinical applications, sufficient information remains in the segmented SLIM images to measure 
fiber–orientation based bio-markers. Another important consideration for clinical applications is 
the relative orientation of tumor adjacent collagen fibers with the tumor boundary. While SLIM 
images can be segmented to digitally remove the epithelial cells, they clearly resolve epithelial 
structures, allowing determination of the tumor boundary orientation with respect to the collagen 
fibers.  
 
 
 
 
57 
 
 
Figure 5.5 The Fourier analysis procedure for computing collagen fiber orientation probability 
densities. (a) SLIM image. (b) Segmented SLIM image. (c) Orientation map of SLIM image. (d) 
SHGM image. (e) Orientation map of SHGM image. (f) Probability density of collagen fiber 
orientation 𝜃 computed from the SLIM orientation map in (c). (g) Bar chart showing the number 
of isotropic and anisotropic regions in segmented SLIM image. (h) Probability density of 
collagen fiber orientation 𝜃 computed from the SHGM orientation map in (e). (i) Bar chart 
showing the number of isotropic and anisotropic regions in SHGM image. The Pearson’s 
correlation 𝜌 between the probability densities for the two modalities is also shown. 
58 
 
5.5.2 Fourier analysis  
 Fourier analysis was carried out on SHGM and segmented SLIM images to extract collagen 
fiber orientation. Each image was sectioned into sub-image regions using grids (16×16, 32×32 or 
64×64), and the localized orientation per sub-image (which we call  ) was determined using the 
Fourier analysis technique outlined in ref. (121). Regions having a mean direction above a chosen 
threshold were referred to as anisotropic regions, while those under this threshold were labeled 
isotropic. In order to highlight preferred orientation in each sub-image, quiver plots were 
superimposed on anisotropic regions to give an orientation map. Histograms of   for anisotropic 
regions (number of bins = 32), and bar plots showing the isotropic and anisotropic region counts 
were also generated from these data. The   histograms were further normalized to obtain 
orientation probability densities ( )SHGP   and ( )SLIMP   .  Figure 5.5 shows the comparable results 
obtained for a selected pair of segmented SLIM and SHGM images. 
5.5.3 Comparison between SHGM and SLIM signals 
 Figure 6 shows the fiber orientation probability densities SHGP   and  SLIMP for three different 
cores, extracted from their respective SHGM and segmented SLIM images. As shown, the shapes 
of the density functions obtained from the two modalities are qualitatively similar for each of the 
cores. In order to obtain a quantitative measure of this similarity, the following procedure was 
used. The cross-correlation between SHGP  and  SLIMP was first obtained and the circular lag 
corresponding to maximum cross-correlation was computed. The two densities were then shifted 
relative to one another by this lag, such that any errors due to overall rotation between the two 
images are minimized. This alignment procedure is required for a fair comparison between the two 
densities because errors in registration of the images from the two modalities can cause one density 
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to be slightly shifted with respect to the other. After alignment, the Pearson’s correlation 
coefficient   between the two densities was computed as a quantitative measure of their similarity. 
The Pearson’s correlation measures the similarity of any two random variables X  and Y , and is 
defined as 
( )( )
.
x y
x y
E X Y 

 
 − − =      (5.7) 
In Eq. 5.7, the operator   E  refers to the expected value and   and   are the mean and standard 
deviation of the random variable in question (125). The correlation coefficient   has values over 
the interval [-1, 1] with -1 referring to perfect negative correlation and 1 corresponding to perfect 
positive correlation. In our analysis, X  and Y refer to the probability densities SHGP  and  SLIMP .  
 The three cores in Fig. 5.6 belong to three different disease stages and, therefore, 
correspond to three different morphologies. As shown, the benign core shows the highest positive 
correlation between SHGP  and  SLIMP with   = 0.93, which decreases to 0.82 for the stage IIa 
malignant core. The lowest correlation is seen for the stage IIIa core which was computed as 0.71. 
This trend can be accounted for by the fact that a core from a patient at an advanced stage of 
disease is more likely to contain large amounts of epithelial tissue. A large proportion of epithelial 
tissue both suppresses the SHG signal and results in greater image segmentation errors in SLIM 
images due to the smaller amount of collagen involved, resulting in lower agreement between the 
two. In addition to the probability densities, the bar charts showing the number of isotropic and 
anisotropic cells counted by the Fourier analysis procedure, are also very similar for both imaging 
modalities as demonstrated in Fig. 5.6.  
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Figure 5.6. Comparison between the fiber orientation probability densities and bar charts 
counting number of isotropic and anisotropic regions for 3 different cores: SHGM (left column) 
and SLIM (right column). This comparison is shown for a benign core (a-b), malignant stage IIa 
core (c-d) and malignant Stage IIIa core (e-f). The similarity of SHGP and SLIMP  is measured for 
each case using the Pearson’s correlation coefficient  , as indicated. Scale bars: 200 µm.  
 
5.5.4 Measuring relative angles of tumor adjacent fibers using SLIM 
 While the results of the last section demonstrate that collagen fiber orientation is 
measurable using SLIM, collagen fiber based histological markers (for example TACS3) are based 
on relative angle r  between tumor adjacent fibers and the nearest point on the tumor or ER edge 
(5, 126).  This angle is schematically illustrated in Figure 5.7. To demonstrate that r  is measurable 
using SLIM, we used a MATLAB based open-source fiber analysis tool called “CurveAlign” (116, 
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127) and extracted r  for 34 benign and 34 malignant cases selected from a TMA. This the same 
TMA that was used for the study in Chapter 4. A description of CurveAlign and specifics of 
parameters used during fiber analysis are included in Section 6.4.7. As discussed in Section 4.3.3, 
all ERs within each core from this TMA had been manually annotated using the region-of-interest 
tool of ImageJ. Before fiber extraction and angle measurement, each ER was segmented out to 
ensure edges of epithelial cells did not interfere with fiber analysis. 
 
 
Figure 5.7 Fiber orientation relative to tumor edge for (a) Benign and (b) Malignant ERs. (c) 
Histogram of relative angles measured for 34 benign and 34 malignant cases, showing that on 
average higher relative angles are measured for malignant tumors. 
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 Figure 5.7 (a) and (b) show benign and malignant ER edges and orientations of fibers 
within their vicinity. Fibers within a distance of 64 m  from the ER edge were associated with 
each ER during this analysis. As is evident from these images, benign ERs have on average lower 
values of r  than malignant ERs. This is both due to the presence of the basement membrane 
around benign epithelium (which tracks its perimeter) but also because invasion in malignant 
epithelium can occur along collagen fibers (5). The results from all epithelium adjacent fibers 
within the 34 benign and 34 malignant cases are summarized in the histogram in Fig. 5.7 (c). As 
shown, there is statistically significant difference between the relative angles measured for benign 
and malignant tissue (determined using the two-sample Student’s T-test). Furthermore, the 
probability of higher values of r  is higher for malignant cases than for benign cases. These data 
agree with previous studies that have linked higher relative angles with worse prognosis (TACS3 
marker) and have suggested that collagen fibers oriented perpendicular to the tumor edge may 
serve as highways for epithelial cell invasion to surrounding tissue (5). 
5.6 Summary and Conclusion 
 Motivated by the relationship between ( )
2  and ( )
1 2[ ]  (Section 5.2), we have presented 
experimental support for the hypothesis that measuring ( )
1
   via phase-resolved imaging, can 
provide ( )
2  information, similar to that obtained in SHGM. Specifically, we have shown that, 
SHGM and segmented SLIM images measure quantitatively similar collagen fiber orientations in 
breast tissue. The conclusions are significant because collagen fiber alignment and orientation are 
potential markers for patient prognosis. We further showed that the relative orientation between 
tumor adjacent fibers and tumor edge, as measured by SLIM, is significantly different between 
cancerous and non-cancerous tissue. While in the past SHGM has been the method of choice for 
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measuring these biomarkers, our results demonstrate the potential of SLIM as a complementary 
method for this assessment. Clearly, compared to SHGM, SLIM lacks the specificity to collagen, 
as the phase image includes signals due to centrosymmetric molecules. As a result, a numerical 
post-processing procedure is necessary to eliminate the isotropic structures from the SLIM image. 
However, these isotropic signals, mainly from epithelial contributions, can be used to delineate the 
glands and potentially, tumor margins. These margins are difficult to detect in SHGM alone and 
other modalities are sometimes used (e.g., two-photon fluorescence microscopy) (117, 128).
 In comparing the optical setups of the two modalities, it is evident that SLIM benefits from 
common components, of much lower cost, compared to those needed in SHGM (e.g., halogen 
lamp vs. femtosecond laser). Furthermore, due to the full-field and continuous wave (CW) 
illumination, SLIM operates at much lower exposures and, thus, is non-perturbing to live cells and 
tissues. For example, SLIM imaging over multiple days without damage is possible (35). The 
acquisition rate of the SLIM system is 0.08 µ𝑠 per pixel as compared to 7 µ𝑠 per pixel for the state 
of the art SHGM system used here. Of course, SLIM signals do not depend on phase matching 
and, as such, the signals are always quantitatively related to the structure under investigation.  
 While we showed in this study that the relative fiber angle, measured using SLIM, is higher 
for cancerous tissue as compared with healthy tissue, future studies that specifically compare 
SLIM based fiber features between cancer patients that have different outcomes are needed. This 
is explored in the next chapter in Section 6.3.5. 
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Chapter 6: QPI of stained breast tissue biopsies 
 
6.1 Abstract 
 Thus far we have presented in this thesis QPI investigations that have relied on imaging of 
unstained tissue. Such an approach poses challenges in clinical adoption of QPI-based disease 
markers because stained tissue is typically assessed in a pathology lab. In this work, we show that 
phase maps of stained tissue, provided by QPI, can be leveraged to extract markers of disease in a 
manner similar to that shown for unstained tissue. We numerically correct for the effects of staining 
on tissue phase maps and show that features extracted from the resulting ‘normalized phase maps’ 
have similar values to those in corresponding unstained tissue. Our imaging system provides these 
maps and traditional bright-field images of stained tissue in a single acquisition. Thus, our 
instrument reduces barriers to clinical translation as a clinician can potentially obtain traditional 
markers of disease as well novel quantitative phase based markers simultaneously. We 
demonstrate the utility of our stained tissue analysis instrument by diagnosing breast cancer 
through supervised learning and measuring collagen fiber based prognostic markers in breast 
tissue. 
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6.2 Motivation and Overview 
  I have demonstrated in the previous three chapters that SLIM based features have utility 
for quantitative breast tissue diagnosis. I also demonstrated that collagen fiber structure can be 
assessed from SLIM images. In both cases, the analysis was performed on unstained tissue 
sections. Staining is an inevitable part of standard histopathology in a clinic so if a pathologist 
wants to look at SLIM based disease markers during investigations, they’ll need to obtain a 
separate dedicated, unstained tissue slice. We propose in this work to bridge this barrier to clinical 
translation in QPI by demonstrating that analyses previously done on unstained breast tissue 
biopsies can be extended to stained tissue. We modified SLIM (48) to provide both phase and 
bright-field microscopy images in a single acquisition. The resulting system is referred to a color 
spatial light interference microscopy (cSLIM). Next a TMA was imaged using SLIM and cSLIM 
before and after H&E staining, respectively. Both sets of raw phase images, ( , )x y , were then 
normalized numerically to obtain normalized phase images ( , )Z x y . For the same TMA core, 
( , )Z x y  maps showed excellent agreement pre- and post-staining indicating their stain 
independence. We further demonstrated that results from supervised learning based detection of 
breast cancer as well as extraction of stromal collagen fiber orientation using these normalized 
phase maps also produces similar results in stained and unstained tissues. Having shown that 
analyses developed for unstained biopsies are extendable to stained ones, we demonstrated the 
ability of our stained tissue analysis system to diagnose histologically difficult cases and to detect 
aligned collagen fiber-based prognostic markers that have been previously shown to correlate with 
outcomes in breast cancer patients. 
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6.3 Results and Discussion 
6.3.1 cSLIM optical setup and outputs 
 The cSLIM optical setup is illustrated in Fig. 6.1. The optical train is based on the 
previously described SLIM system (48) with two important modifications. First, in the place of 
the phase contrast microscope objective used in SLIM we employ a 40x/0.75 NA bright-field 
objective. The use of a bright field objective allows us to obtain typical H&E stained histology 
images that are the mainstay of breast histopathology in the clinic. The annular condenser ring is 
retained from the SLIM system. Second, the grayscale camera is replaced by a color RGB camera 
(Carl Zeiss Axiocam MRc) which provides red, green and blue spectral channels of information. 
The remainder of the system operates as previously described for SLIM:  The SLIM module 
(CellVista SLIM Pro, Phi Optics, Inc.) is placed at the output port of a commercial microscope. 
The conjugate image plane at the microscope output port is imaged onto the camera using a 4f 
system formed by lenses L1 and L2. At the Fourier plane of lens L1 an SLM (Boulder Nonlinear 
Systems) is used to modulate the phase difference between the scattered and incident components 
of light. As illustrated in Figs. 6.1 (c) and (d), four modulations, 0, / 2, , 3 / 2   = rad, are 
employed. For each modulation, we acquire three intensity frames corresponding to the red, green 
and blue channels of the camera: ( , ; ), ( , ; )R x y G x y   and ( , ; ),B x y   respectively. In each case, 
these channels are combined to obtain an equivalent grayscale intensity image using the formula 
 ( , ; ) 0.1 ( , ; ) 0.6 ( , ; ) 0.3 ( , ; )I x y R x y G x y B x y   = + + . (6.1)   
 The weighting attached to each channel was determined empirically and is related to the 
resulting wavelength at which phase modulation occurs between the scattered and incident light in 
cSLIM [see Section 6.4.3 of the Methods section for details]. Thus four intensity frames ( , ; )I x y   
are acquired for each phase map, ( , )x y , reconstruction. The phase reconstruction process using 
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these four frames is identical to that previously published for SLIM (48) and is typical of phase 
shifting interferometers (46).  
 The modifications to the original SLIM system required us to perform two calibration 
steps. First, SLM re-calibration was required to ensure that the correct value of   is used for each 
of the four frames (48). This was performed by configuring the SLM in amplitude mode and 
measuring the amplitude modulation in ( , ; )I x y   as a function of the SLM 8-bit grayscale input 
(48). The calibration curve for phase was then obtained by taking the Hilbert transform of the 
amplitude modulation curve [see Section 6.4.3 for details]. Second, the SLIM phase reconstruction 
algorithm includes the attenuation term pc  which is the factor by which incident light is attenuated 
with respect to the scattered light in a phase contrast objective. Since bright field objectives do not 
impart his attenuation, an equivalent attenuation bf was introduced numerically in place of pc in 
the SLIM phase reconstruction. The correct value of bf  was determined by imaging an unstained 
TMA core using both phase contrast and bright field objectives and tuning bf until the similarity 
between the phase maps from the two acquisitions was maximized [see Section 6.4.4]. The final 
value of 3.4bf = was then used for all subsequent phase reconstructions. 
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Figure 6.1 cSLIM optical setup. (a) A commercial microscope with phase contrast illumination 
and bright-field objective. (b) SLIM module placed at the microscope output port, equipped with 
color RGB camera. (c) Phase shifts imparted between scattered and incident light by the SLM in 
the Fourier plane of L1. (d) Four intensity frames obtained for each phase modulation by 
weighted sum of the red, green and blue channel images of the RGB camera. IP, image plane, 
SLM, spatial light modulator. 
 
 The typical raw outputs generated by the cSLIM system are illustrated in Fig. 6.2. Results 
are shown for an H&E stained TMA at the slide [Figs. 6.2 (a) and (d)], core [Figs. 6.2 (b) and (e)] 
and cellular scales [Figs. 6.2 (c) and (d)]. As shown, whole slide phase and bright-field microscopy 
images are obtainable in a single scan. The scan time for a single core (approx. 1 mm2 area) was 
approx. 13 secs at a sampling rate of 7.4 pixels/ m . A key advantage of the cSLIM outputs is that 
perfectly registered standard histopathology and quantitative phase images are obtainable. This is 
significant in carrying out QPI studies with large cohorts since independent pathologist evaluation 
can be done on the same tissue rather than a parallel section. This ensures that a pathologist’s 
diagnosis matches precisely with markers extracted in QPI without the need for duplicate scanning 
of tissue section before and after staining. Furthermore, information from both channels (phase 
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and bright-field) can be combined for improving results of classification and segmentation 
problems for which algorithms related to both modalities have been published, separately thus far, 
in literature (19, 20, 25, 87). 
Figure 6.2 cSLIM outputs obtained by scanning a whole TMA slide. (a)-(c) H&E stained tissue 
bright-field images of whole slide, single core and epithelial region within core, respectively. 
(d)-(f) Raw phase maps of  whole slide, single core and epithelial region within core, 
respectively. 
 
6.3.2 Normalizing effects of staining 
 The spectrum of light is not identical between the SLIM and cSLIM systems – there is a 
difference in both the spectral width (determined by the coherence length cl ) as well as the central 
wavelength 0 . For the SLIM system 0 589 nm =  and 2.26cl m=  in air whereas for cSLIM, in 
the absence of tissue, 0 558 nm =  and 3.24cl m=  also in air [see Methods Section 6.4.3]. When 
stained tissue is present, the cSLIM spectrum the will vary even further due to absorption (refer to 
Appendix A for analysis of dispersion in tissue). As a result, phase maps extracted from stained 
and unstained tissue samples differ. To quantify this difference we imaged a TMA of breast tissue 
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biopsies before H&E staining using SLIM and after staining using cSLIM. We refer to this TMA 
as “TMA-1” in the rest of the chapter [refer to Methods Section 6.4.1 for details about TMA-1]. 
This is the same TMA that was used in ref. (87)  and Chapter 4 for separating normal and cancerous 
cases using SLIM based features. The raw phase maps ( , )x y  for one TMA core, before and after 
staining, are illustrated in Figs. 6.3 (a) and (b), respectively. It is evident that staining causes a 
reduction in phase values as well as the image contrast. These effects are also illustrated in the 
histograms of the two phase images in Fig. 6.3 (c) where the stained tissue histogram is noticeably 
narrower. To normalize these effects of staining we computed, for each core, the standard normal 
variable ( , )Z x y  from ( , )x y  using the equation 
 
( , )
( , )
x y
Z x y
 

−
=   (6.2) 
where  is the mean of ( , )x y  in the tissue region within each core image (after segmenting out 
background pixels) and  its standard deviation. Details about this computation, including 
removal of background pixels, are described in Methods, Section 6.4.5. 
 The results of this normalization procedure are shown in Figs. 6.3 (d) – (f). As shown, the 
normalized phase maps are visually very similar between stained and unstained tissue and the 
histograms seem to overlap almost perfectly. To quantify this similarity, the Pearson’s correlation 
coefficient   (125) was computed between the stained and unstained tissue histograms, both 
before and after phase normalization. As illustrated in Figs. 6.3 (c) and (f), the   values improved 
significantly due to the normalization procedure (were in fact almost equal to 1), indicating a very 
high degree of correlation. The   values for a total of 30 cores (15 cancerous and 15 normal, 
selected randomly from TMA-1), before and after normalization, are summarized in Fig. 6.3 (g). 
The bar heights represent mean values whereas the error bars represent the standard deviations 
71 
 
over the 30 cores. The ( , )Z x y  maps are, thus, consistently more similar before and after staining 
than ( , )x y maps indicating a stain independent signal in the normalized images. Benign and 
malignant tissue have different stain distributions due to differing proportions of epithelium and 
stroma as well as a different cellular phenotype. In addition, the cores used for this analysis were 
selected randomly from different parts of the TMA slide, meaning that their staining intensities 
can potentially vary due to local variations in staining agent concentration. Despite these sources 
of variation, our normalization technique is robust and works well across the cores considered. 
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Figure 6.3 Comparison of phase maps obtained from the TMA-1 before and after staining. (a) 
and (b) TMA core raw phase images before and after staining, respectively. (c) Histograms of 
the phase images in (a) and (b). The similarity of the two histograms is quantified by computing 
the Pearson’s correlation coefficient   between them. (d) and (e) Normalized phase maps for the 
same core before and after staining, respectively. (f) Histograms of the phase images in (d) and 
(e). The similarity of the two histograms is quantified by computing the Pearson’s correlation 
coefficient   between them. (g) Bar plots showing the mean value of Pearson’s correlation 
coefficient   between core histograms for raw and normalized phase maps. Error bars show the 
standard deviation over the 30 cores. 
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 Computation of ( , )Z x y  minimizes the difference between SLIM and cSLIM results 
because division by standard deviation removes the 1 /   dependence of the phase maps so that 
variations due to different 0  between the two systems, in absence of absorption in tissue, are 
minimized (for details see Appendix A). While dispersion in tissue (spatial variation of both 
wavelength and refractive index) is also expected to cause differences between these images, our 
detailed analysis of this phenomenon (included in Appendix A) showed that these changes are 
small. The fact that a global normalization is effective in removing the stain-related effects also 
indicates that dispersion in tissue is not a dominant effect (see Appendix A). 
 
6.3.3 Breast cancer diagnosis on stained tissue biopsies using supervised learning 
6.3.3.1 Classifying benign versus malignant cases 
As stated earlier, features extracted from SLIM images of unstained tissue have been 
shown to detect malignancy in different organs (50, 52, 87). In ref. (87) and Chapter 4  we 
developed a supervised learning method for breast cancer diagnosis that relied on three types 
of features extracted from SLIM images: the median gland or ER curvature C  , the median 
of mean scattering length within an ER sl   and the median texture vector for the ER T  . 
These features were extracted from and compared between benign and malignant ERs within 
a TMA (unstained TMA-1 was used in that study). 3-fold cross-validation results showed an 
AUC of 0.91 during ROC analysis of the classification (87). 
To demonstrate that this analysis can be extended to stained tissue cores, for the 15 
malignant and 15 benign cores selected from TMA-1 in the previous section, we assembled 
( , )Z x y  maps both before and after staining. Each core belonged to a different case/patient. All 
malignant cases were diagnosed as IDC whereas the all benign cases were diagnosed benign 
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without atypia (BWA) by a certified pathologist. From the ( , )Z x y  maps of each core, the same 
feature set  , ,sC l T       was extracted for each ER. Pathologist diagnosis for each ER 
was available and was used as the ground truth for training [see Section 6.4.1 for details]. The 
classification scheme developed for ( , )x y  in Chapter 4 was repeated for ( , )Z x y in both 
stained and unstained cases and the results were compared. Details of the feature extraction, 
training and validations steps, specific to this study, have been included in Methods, Section 
6.4.6. 
Figure 6.4 illustrates the diagnosis results obtained for stained and unstained tissue. 
Figs. 6.4 (a), (b), (d) and (e) compare ( , )Z x y for example benign and malignant ERs before 
and after staining. As shown, once again the images are very similar between the before and 
the after. In cSLIM, morphological details of these ERs are also available for traditional 
histopathological assessment through bright-field images [Figs. 6.4 (g) and (h)]. To test 
whether features derived from these ( , )Z x y  maps can detect malignancy in breast tissue, 3-
fold cross-validation was performed, consisting of three trials. ERs from all cores were pooled 
and divided into three equal sets and in each trial two sets were used for training and one set 
for validation. Figs. 6.4 (g) and (h) compare the values of the three features between unstained 
and stained ERs, for one training set. Since texture feature T   is multidimensional, it is 
represented by its first principal component in the plot. As is noticeable, the feature values 
have a similar distribution for both benign and malignant ERs between the unstained and 
stained cases. 
In each case, the probability scores for all ERs, generated by an LDA classifier in all 
three trials, were pooled together to generate an ROC curve for the cross-validation [see 
Section 6.4.6]. As shown in Fig. 6.4 (i), similar AUCs were measured for analysis on both 
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stained and unstained tissue using ( , )Z x y  maps, indicating that detection of malignancy is 
achievable at high accuracy using stained tissue biopsy phase maps. While the AUCs are 
similar, they are not identical. This can be attributed to the fact that the tissue morphology itself 
(while similar) is not identical between the two experiments since the process of removing the 
coverslip from the TMA slide and staining it results in some physical changes to the tissue 
biopsies, in addition to those due to staining.  
 
Figure 6.4 Comparison of diagnosis results between stained and unstained tissue using ( , )Z x y
maps. (a)-(b) ( , )Z x y images of an unstained and stained malignant ER, respectively (c) H&E 
stained bright-field image of the same malignant ER. (d)-(e) ( , )Z x y images of an unstained and 
stained benign ER, respectively. (f) H&E stained bright-field image of the same benign ER. (g)-
(h) Separation of benign and malignant ERs in feature space for stained and unstained tissue, 
respectively. (i) ROC curves for 3-fold cross-validation for classifying benign and malignant ERs. 
 
76 
 
6.3.3.2 Screening of high-risk and low-risk breast lesions using cSLIM 
Having demonstrated that our feature set has the ability to detect malignancy on stained 
tissue biopsies, we next applied our model to a more diagnostically challenging problem. 
Stratification of benign lesions in breast tissue during histopathology is a significant challenge 
for pathologists (15, 129, 130). One of the key questions is finding a consistent and quantitative 
basis for separating cases of benign atypical hyperplasia (BAH) from cases of BWA. QPI based 
markers can help pathologists during these borderline investigations by supplementing the 
information available in traditional histopathology with quantitative markers. To demonstrate 
that our feature set is capable of stratifying benign lesions, we imaged a second H&E stained 
TMA consisting of  9 cases of BAH (2 cores per case), 9 cases of IDC (2 cores per case) and  
17 cases of BWA (2-3 cores per case). We refer to this TMA as ‘TMA-2’ in the rest of the 
chapter. Details regarding TMA-2 are included in Section 6.4.1. TMA-2 was imaged using the 
cSLIM system and ( , )Z x y  maps for each core were assembled. Figs. 6.5 (a) and (b) show the 
bright-field and ( , )Z x y  maps for an ER with BAH, acquired by the cSLIM system. Examples 
of ERs diagnosed as BWA and IDC have already been shown in Fig. 6.4. 
The cores in TMA-2 were used to construct two groups: a high-risk group consisting 
of 18 cases (IDC and BAH) and a low-risk group consisting of 17 cases (BWA). This study 
design is illustrated in Fig. 6.5 (c). The data were partitioned in this way because diagnosis of 
BAH, while not considered a diagnosis of cancer, has clinical significance and patient follow-
up is carried out to ensure further progression of disease is prevented (129, 130). A patient 
diagnosed with BAH is, therefore, placed into a higher risk category than a patient diagnosed 
as BWA (129). Pathologist diagnosis for each ER was available within each case and was used 
as the ground-truth during analysis [see Methods, Section 6.4.1]. Using the same feature 
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extraction and training procedures as used to separate cancer from non-cancer in part (a) of 
this section, a binary classifier was developed for separating high-risk and low-risk groups. 
Once again 3-fold cross validation was employed to assess classifier accuracy. Classifier 
probability scores from all three trials were pooled together to generate an ROC curve for 
cross-validation [Methods, Section 6.4.6] which is illustrated in Fig. 6.5 (d). A cross-validation 
AUC of 0.81 was obtained for separating the high-risk and low-risk groups. Since pathologist 
agreement on BAH diagnosis through H&E stained tissue histopathology is low [concordance 
rate of 48% was reported in (15)] and often additional IHC based markers are needed to help 
with diagnosis (130), our cSLIM based markers can provide an additional channel of 
information to a pathologist, helping them determine whether or not the patient is high-risk 
and, thus, requires further investigations/procedures. 
 
Figure. 6.5 (a) Bright field and (b) Normalized phase image of a benign ER with atypical ductal 
hyperplasia. (c) Study design for screening out high-risk cases from low risk cases (d) ROC for 
separating high-risk ERs from low risk ERs. 
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6.3.4 Collagen fiber orientation measurement on stained tissue 
 The prognostic value of tumor-adjacent collagen signatures (TACS) in breast tissue has 
been demonstrated in a number of studies (5, 111). Traditionally, these markers have been 
measured using SHGM which provides chemical specificity to collagen. However SHGM has 
disadvantages in that the tumor edge is difficult to identify due to low contrast in cellular structures 
and the acquisition speed is slower than conventional microscopy due to a point-scanning 
geometry (118). We demonstrated in ref. (118) and in Chapter 5 that SLIM phase images of 
unstained tissue can be used to quantify collagen fiber orientation in breast tissue. Here we 
demonstrate that the relative angle r  between collagen fibers near an ER edge and the tangent to 
the nearest point on the edge itself is detectable on stained tissue biopsies. r  is schematically 
illustrated in Fig. 6.6. 
 For the 30 cases selected from TMA-1 (used in the previous two sections) we measured r  
in the ( , )Z x y maps of both stained and unstained tissue using an open source MATLAB based 
tool called CurveAlign (116) [see Methods Section 6.4.7 for details and parameter specifications]. 
All fibers within a distance of 63 m  from the ER edge were considered. This is within the range 
of the typical intercellular signaling distance reported in literature (116, 131). ERs in all cores were 
segmented out before computation of r  so that their cellular structures did not interfere with the 
process of collagen fiber extraction [see Section 6.4.2 of methods for details on ER segmentation].   
 Figure 6.6 compares the obtained results between unstained and stained tissue biopsies. 
Figures 6.6 (a) and (b) show the bright-field images of malignant and benign ERs whereas Figs. 
6.6 (c), (d), (f) and (g) illustrate the fiber orientation in their vicinity. As evident from these images, 
values of r  are on average higher for malignant tissue than for benign. Furthermore, the 
orientation measured on stained tissue qualitatively matches that measured on unstained. Figures 
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6.6 (e) and (h) show the histograms of r  measured for all tumor adjacent fibers within the 30 core 
dataset. Once again not only are the values comparable between stained and unstained tissue 
samples but also in both cases malignant ERs show a greater probability of forming higher angles 
with their adjacent fibers. These measurements agree with previous results in literature where it 
was demonstrated that higher values of r  are associated with more aggressive disease and that 
aligned collagen fibers, oriented perpendicularly to tumor edge, facilitate local invasion (5). The 
results here are also significant because collagen fiber based parameters show similar values 
between stained and unstained normalized phase maps. This means that prognostic markers related 
to stromal fibers too can, potentially, be evaluated using cSLIM while simultaneously having 
access to bright-field standard histopathology images (as demonstrated in the next section). 
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Figure 6.6 Comparison of relative collagen fiber angle r  between stained and unstained tissue 
biopsies. (a) and (b) Bright-field images of malignant and benign ERs, respectively. (c) and (d) 
Orientation of collagen fibers in stained tissue, in the vicinity of malignant and benign ERs, 
respectively. Fiber orientations are shown as green lines while the ER edge is marked in orange. 
(e) Normalized histogram of r  measured for all ERs within the stained tissue dataset (15 
malignant and 15 benign cores). (f) and (g) Orientation of collagen fibers in unstained tissue in 
the vicinity of malignant and benign ERs, respectively. Fiber orientations are shown as green 
lines while the ER edge is marked in orange. (h) Normalized histogram of r  measured for all 
ERs within the unstained tissue dataset (15 malignant and 15 benign cores). p-values in both 
cases were computed using the two-sample Student’s T-test. 
 
6.3.5 Quantifying aligned collagen fibers in stained tissue for prognosis  
 Having demonstrated in the last section that fiber extraction and orientation measurement 
is possible in cSLIM images of stained tissue, in this section we formally measure the prognostic 
marker TACS3. TACS3 refers to the presence of aligned collagen fibers that terminate at the tumor 
edge at high (near perpendicular) values of relative angle r . In Bredfeldt et al. (116), TACS3 was 
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measured using an automated, supervised learning scheme within a TMA imaged using SHGM. 
We imaged the same H&E stained TMA, referred to in the rest of the chapter as TMA-3, using 
cSLIM and extracted ( , )Z x y  maps for each core. The analysis method from ref. (116) was then 
repeated on these maps to demonstrate that cSLIM can also detect TACS3. Details regarding 
TMA-3 have previously been published and are summarized in Section 6.4.1.  
 TMA-3 comprised 196 cases (1 core per case) of IDC with disease free survival (DFS) and 
disease specific survival (DSS) information available for each case (5). Using open-source 
MATLAB based tools CT-FIRE (116, 127, 132) and CurveAlign, features were computed for each 
fiber that was within a distance of 100 m  from the tumor edge [see Section 6.4.9 for details on 
fiber extraction and feature computation]. Once again this distance was chosen bearing in mind 
the typical intercellular signaling distances reported in literature (131). For each core, the features 
extracted from each fiber were then combined to generate a feature vector for the core. Three core-
level features were found to be most informative in distinguishing TACS3 positive and negative 
patients: mean of    (mean nearest fiber alignment), mean of l  (nearest distance of fiber from 
tumor edge) and skewness of r .  These features are listed in the table in Fig. 6.7 (a). Their detailed 
description has already been published (116, 127) and is also described in Methods, Section 6.4.9. 
Feature vectors for 10 cores marked as TACS positive and 10 cores marked as TACS3 negative 
[based on pathologist consensus (5)] were used as predictors for training a linear Support Vector 
Machine (SVM) classifier. The classifier was then used to classify all 196 cores as either TACS3 
positive or TACS3 negative. Figure 6.7 (a) shows the difference in the feature means of groups 
classified as TACS3 positive and TACS3 negative. According to these mean values, cores 
classified as TACS3 positive have a higher probability of containing aligned fibers (high  )  that 
terminate at or near the tumor edge (low l ). Furthermore, these cores have r  histograms that are 
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more positively skewed, reflecting an asymmetry due to more instances of high r . These 
measurements agree with the pathologist definition of TACS3, indicating successful classification. 
 Survival analysis was carried out to test whether patients classified as TACS3 positive had 
significantly worse outcomes than those deemed TACS3 negative. Figure 6.7 summarizes the 
results of this analysis. Univariate cox proportional hazard regression and Kaplan-Meier estimates 
were used to compare survival between TACS3 positive and TACS3 negative cases. As shown in 
Fig. 6.7 (b), TACS3 positive patients had hazard ratios of greater than 2 and p-values < 0.05, 
representing a statistically significant chance of worse DSS and DFS outcomes. This trend is also 
evident in the Kaplan-Meier estimate of the DFS and DSS survival functions [Fig. 6.7 (c)] where 
TACS3 positive patients show significantly higher frequency of events. The p-values in this case 
were computed using the log-rank test (133). Finally we also computed the Pearson’s correlation 
coefficient   between the computationally generated TACS3 scores on cSLIM images and 
manual scores generated by pathologists [see ref. (5) for details] . As shown in Fig. 6.7 (d), a 
positive correlation was measured in each case, indicating that the automated analysis extracted 
the same or similar histological markers as were observed by the pathologists manually. 
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Figure 6.7. Results of survival analysis for TACS3 positive and TACS3 negative groups, 
classified based on fiber features measured from cSLIM ( , )Z x y  maps. (a) Fiber features found to 
be most informative in classifying cores as positive or negative. p  and n  refer to the mean of 
these features for the groups classified as positive and negative, respectively. (b) Results of the 
univariate cox proportional hazard regression with TACS3 status as variable. (c) Kaplan-Meier 
estimate of survival function for DSS and DFS. Vertical tic marks represent right-censoring events. 
The number of cores classified as TAC3 negative were 52 and those classified as TACS3 positive 
were 144. (d) Pearson’s correlation between the automated TACS3 scores and the 3 different 
manual pathologist scores (5).  
 
 Our results are significant because while TACS3 has been measured automatically using 
SHGM before, the cSLIM system provides important advantages over SHGM in terms of both 
speed and the fact that both phase and bright field images of epithelial tissue are obtainable in a 
single acquisition. As has been pointed out throughout this paper, a cSLIM based instrument will 
allow the assessment of traditional prognostic markers (e.g tumor grade and molecular subtype) as 
well as new prognostic markers (such as TACS3) in a single scan, posing modest new requirements 
84 
 
on instrument optics and no new requirements on sample preparation, compared with standard 
histopathology. 
6.4 Methods 
6.4.1 TMAs 
 TMA-1 was purchased unstained from US Biomax (Serial # BR1002) and comprised cases 
of IDC and normal benign tissue. The TMA was obtained from the manufacturer with all human 
subject identifiers removed and neither the author nor their institution were involved in the tissue 
collection. Details regarding this TMA have already been reported in ref. (87) and Chapter 4. For 
each case diagnosis was provided by the manufacturer’s board certified pathologist through 
examination of both H&E stained tissue and IHC makers, both on parallel sections of tissue. After 
acquiring SLIM images, the TMA was H&E stained for cSLIM imaging using standard protocols 
(13). Before staining, the coverslip was removed from the slide and post-staining the slide was re-
coverslipped using the same mounting medium as before (Xylene). As discussed in Results and 
Discussion, 15 cases of IDC and 15 cases of normal tissue (diagnosed as BWA by the 
manufacturer’s pathologist) were randomly selected from the TMA for the studies discussed in 
this chapter. 1 core per case was available. Each biopsy core had a diameter of 1 mm and thickness 
of 5 m . For the IDC cases, a second board certified pathologist also marked any benign regions 
within the tissue cores which were then excluded from the analysis. In this way, diagnosis of each 
ER within each core (BWA or IDC) was available. 
 TMA-2 was purchased, already H&E stained, from US Biomax (Serial # BR1003) and 
comprised cases of IDC, BAH and BWA. Within the BWA cases, cases of benign usual 
hyperplasia (BUH) were also available. The TMA was obtained from the manufacturer with all 
human subject identifiers removed and neither the author nor their institution were involved in the 
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tissue collection. This is the same TMA slide that was used in the study published in ref. (134). 
Each biopsy core had a diameter of 1 mm and thickness of 5 m . For all cases in TMA-2, diagnosis 
was provided by the manufacturer through inspection by a board certified pathologist. The 
diagnosis was based on inspection of H&E stained tissue as well as evaluation of IHC based 
markers, on a parallel tissue section. For each core, the tissue block from which it was extracted 
was also examined to ensure correct diagnosis had been reached for the core. Since pathologist 
agreement on cases of BWA and IDC is high [reported as 97.1 and 97.7% in (129)] while that for 
BAH is low [<50% in (129)] the cores diagnosed as BAH by the first pathologist were re-examined 
by a second board certified pathologist. The second pathologist confirmed the BAH diagnosis of 
the first pathologist. Since we classify each ER as high risk/low risk in our method, all high-risk 
cores (IDC and BAH) were also examined by the second pathologist for low-risk regions (benign 
lesions without atypia), which were removed from analysis. In this way diagnosis for each ER 
(low-risk or high-risk) was available for all cases within TMA-2. 
 TMA-3 was used in previous studies by Bredfeldt  et al. (116) and Conklin et al.(5). Details 
regarding patient profiles, tissue processing and core selection have already been described in ref.  
(5). The dataset used from the TMA consisted of 196 cores (1 core per patient) and patients were 
followed up for a median time of 6.2 years, ranging from 1-223 months in order to determine 
patient outcomes. DSS and DFS information was available for each patient. DSS was defined as 
the time from diagnosis to death from breast cancer or date of last follow up evaluation. DFS was 
defined as the time from date of diagnosis to the first date of recurrence. The TMA-3 was H&E 
stained using standard protocols (13), allowing for simultaneous acquisition of both normalized 
phase and bright-field images using the cSLIM system. All tissue and patient information were 
obtained after approval by IRB (5). 
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 Analysis of required sample size based on statistical power of 0.8 and two-sided p-value 
of 0.05 (using log-rank test) was performed using the method described in (135). Using the 10-
year survival fractions in the Kaplan-Meier curves (Fig. 6.7) to compute the Hazard Ratio (135), 
the required sample size was estimated as 
reqN  = 100 cases for DFS and reqN  = 150 for DSS.  
These are both smaller than the 196 cases we used in our study. During this analysis proportions 
of TACS3 positive and TACS3 negative cases were based on the results of the SVM classifier 
(Section 6.3.5). 
6.4.2 Epithelial tissue segmentation for feature extraction 
 For computation of epithelial features during supervised learning as well for measurement 
of relative fiber orientation, knowledge of the ER boundary is required. For TMA-1 and TMA-2, 
the ER boundaries were annotated in all the cores manually using the region-of-interest tool in 
ImageJ by using the H&E stained tissue bright-field images as a guide. Consistent criteria were 
used during annotation– groups of epithelial cells bounded by stroma on all side were considered 
a single ER. Other tissue components were considered part of the ER if surrounded on all sides by 
epithelial cells (87).  
 The ER segmentation procedure for TMA-3 has already been described in ref. (116). A 
supervised automated classification scheme, relying on features derived from tissue bright-field 
images, was used in that case. We used the same ER segmentation masks for the studies done in 
this chapter. Registration of ( , )Z x y  maps with segmentation masks was carried out by first 
registering the cSLIM bright-field images with the bright-field images from the original study. 
Speed-Up Robust Features (SURF)(136) were extracted on both sets of bright-field images and an 
affine transform for registering them was found. This transform was then applied to the ( , )Z x y  
maps to register them with the ER segmentation masks.  
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6.4.3 SLM calibration with RGB camera 
 SLIM requires SLM calibration so the correct phase modulation is applied between the 
scattered and incident components of light (48). This calibration is different for different light 
spectra due to the wavelength dependent nature of the SLM liquid crystal response. The spectra of 
light in SLIM and cSLIM are different in terms of both spectral width and central wavelength. 
This illustrated in Fig. 6.8. Fig. 6.8 (a) compares the measured spectra of two modalities. The 
spectrum in SLIM is simply that of the illumination source whereas to obtain the cSLIM spectrum 
one has to multiply the illumination spectrum with the spectral response of the red, green and blue 
channels of cSLIM [see Eq. (A.1) in Appendix A]. From these spectra, which were measured as a 
function of wavelength  , we obtain the frequency dependent spectra as function of angular 
frequency   (which requires re-sampling and rescaling)(48). By taking the Fourier transform of 
these frequency spectra we obtain the temporal autocorrelations for both modalities, shown in Fig. 
6.8 (b). The central wavelength 0  and the coherence length cl  extracted from these correlation 
functions are different: the cSLIM spectrum is slightly blue-shifted and the modality has a longer 
coherence length than the SLIM. cl  here is defined as the full-width half maximum (FWHM) of 
the envelope [dashed line in Fig. 6.8 (b)] of the autocorrelation function. 
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Figure 6.8 (a) Comparison of SLIM and cSLIM spectra. The raw spectra were normalized to 
make the sum over all wavelengths equal to 1. (b) Autocorrelation functions obtained by taking 
the Fourier transforms of the spectra in (a). (c) Amplitude (intensity) modulation curve obtained 
in cSLIM by configuring the SLM in amplitude mode. (d) Hilbert transform of the amplitude 
modulation curve in (c) provides the phase calibration. 
 
 For these reasons, recalibration of the SLM was required for the cSLIM system. After 
configuring the SLM in amplitude modulation mode (48), the 8 bit grayscale input to the SLM 
was scanned from 0-255. The corresponding amplitude modulation in ( ), ;I x y   was measured and 
each frame was averaged to generate a one dimensional amplitude modulation curve, shown in 
Fig. 6.8 (c). By taking the Hilbert transform of this curve, the SLM calibration curve, relating 
phase values to grayscale input, was obtained. The grayscale values corresponding to 
0, / 2, , 3 / 2   = rad were used in all imaging experiments.    
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6.4.4 Attenuation calibration for bright-field objective 
 Phase contrast objectives contain a phase plate in their back focal planes that not only 
introduces a / 2  rad phase shift between the unscattered light 0U  and scattered light 1U  but also 
imparts an attenuation factor 1
0
| |
| |
pc
U
U
 = . This factor is used during SLIM phase reconstruction 
while calculating the ratio of the amplitudes of the two interfering fields (48, 137). In our cSLIM 
experiments, we have used a bright-field objective that does not have this attenuating element. An 
equivalent value of attenuation, 
bf , was, therefore, used during phase reconstruction. bf was 
obtained through the following calibration procedure which is illustrated in Fig. 6.9. An unstained 
TMA core was imaged using cSLIM with both a phase contrast and bright-field objective. During 
phase reconstruction for the phase contrast case, the measured attenuation factor 1.97pc =  was 
used and the raw phase image ( , )x y  was obtained [Fig. 6.9 (c)]. For the bright-field case the 
equivalent attenuation 
bf  was numerically tuned and the phase ( , )x y was obtained for each bf . 
For each 
bf  the cross-correlation ( , )pc bfP P  between the probability distributions pcP  and bfP  of 
( , )x y in the phase contrast and bright-field cases, respectively, was measured (138). 
pcP  and bfP
were obtained by normalizing their respective image histograms (constructed with 512 bins each). 
As shown in Fig. 6.9 (b), ( , )pc bfP P maximizes at 3.4bf =  which was, thus, the value used for all 
subsequent imaging experiments. Fig. 6.9 (d) shows the phase image obtained using the bright-
field objective at 3.4bf = which has similar values to the corresponding phase contrast objective 
image [Fig. 6.9 (c)]. 
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Figure 6.9 (a) Attenuation 
pc  of the unscattered light 0U  with respect to scattered light 1U in a 
phase contrast objective. For imaging with a bright-field objective this term is introduced 
numerically, 
bf . (b) Cross-correlation   between the probability distributions pcP  and bfP  of the 
same unstained TMA core measured using phase contrast and bright-field objectives, 
respectively.   is measured for different values of bf and maximizes at bf = 3.4. (c) cSLIM 
image of the unstained tissue core obtained using a phase contrast objective with the measured 
value of attenuation 1.97pc = . (d) cSLIM image of the unstained tissue core obtained at the 
optimum value of 
bf = 3.4. 
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6.4.5 Procedure for stain normalization  
 As discussed in Results and Discussion Section 6.3.2, we extracted the normalized phase 
maps ( , )Z x y  from the raw phase maps ( , )x y generated by the cSLIM system, using Eq. (6.2). 
This computation is illustrated in Fig. 6.10. For each tissue core ( , )x y  map we first generated a 
segmentation mask [Fig. 6.10 (b)] using thresholding followed by morphological operations 
(morphological closing and removal of connected objects smaller than a certain number of pixels). 
A circular structural element for morphological closing was used and its diameter was determined 
iteratively. This mask was then used to calculate the mean   and standard deviation   of the 
foreground region in ( , )x y  (region occupied by tissue core). Finally, the ( , )Z x y image was 
computed for the core from these parameters as shown in Figs. 6.10 (c) and (d). 
92 
 
 
 
Figure 6.10. (a) Raw phase map of stained TMA core. (b) Mask for computation of   and   
over foreground pixels. (c)-(d) Computation of normalized phase map. 
 
6.4.6 Classification scheme for cancer diagnosis 
 The supervised classification of first benign versus malignant lesions, followed by low-risk 
versus high-risk lesions [Section 6.3.3 of Results and Discussion] is based on the procedure we 
reported in ref. (87) and described in Chapter 4. The procedure can be divided into three main 
steps: feature extraction, training and validation.  
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 During feature extraction, first maps of the ER curvature C , mean scattering length sl  and 
texture vector T  were extracted for each core within our datasets. The ER curvature C refers to 
the extrinsic curvature of a two-dimensional plane (in this case a benign or malignant ER) and can 
be construed as the magnitude of the rate of change of a vector tangent to the ER perimeter. We 
used an open-source MATLAB code to measure C  for each annotated ER (89). The mean 
scattering length sl  is the length-scale over which a single scattering event happens on average and 
can be computed from tissue phase images using the scattering-phase theorem (57). The texture 
vector T consists of frequencies of elements known as ‘textons’ within the vicinity of a pixel in 
the image. Textons have been shown to be effective measures of the unique texture surrounding a 
pixel (25, 90, 91).  For the straightforward benign versus malignant classification, contrary to our 
previous work where 50 textons were trained (resulting in a 50 dimensional vector T ), we trained 
30 textons due to the smaller size of the dataset (87). For classifying low-risk and high-risk lesions, 
once again 30 textons were trained. In each case, this number was obtained iteratively by 
measuring the cross-validation AUC (discussed below) while increasing the number of textons 
and stopping at the point where no improvement in AUC was noticed, to avoid overfitting. For 
feature extraction, all other parameters were identical to those used in ref. (87). 
 After pixel-wise computation of these features, the median over each ER was calculated 
for each feature  , ,sC l T      , using the ER masks obtained through manual segmentation 
[Section 6.4.2]. These were then concatenated to generate an overall (32 dimensional) feature 
vector for each ER. Using pathologist diagnosis for each ER as the class label (benign or malignant, 
low risk or high risk) and its overall feature vector as the predictor, an LDA classifier was trained. 
During validation, feature vectors for an unknown ER were input to the classifier which generated 
a likelihood score for the ER belonging to either class. The overall data set was partitioned into 
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three equal sets. Three validation trials were performed (3-fold cross validation) (93) and in each 
trial two sets were used for training and the remaining set for validation. The classifier performance 
was measured using ROC analysis. Likelihood scores for each ER, generated by the classifier from 
the three validation trials, were pooled together (95) to generate an overall ROC curve [Figs. 6.4 
(i) and 6.5 (d) ] and the area AUC was used as a metric for classifier accuracy.  
6.4.7 Fiber orientation extraction on TMA-1 using CurveAlign 
 In Results and Discussion Section 6.3.4, we compared r , the relative angle between the 
orientation of a collagen fiber and the tangent to the nearest point on the tumor edge (depicted in 
Fig. 6.6), between benign and malignant cases. The results were extracted using an open source 
MATLAB based tool called CurveAlign, algorithmic details of which have already been described 
in a number of publications (115, 116, 127, 139). For our analysis in Section 6.3.4, we chose the 
Curvelet Transform (CT) based fiber analysis method within CurveAlign. This method uses the 
curvelets provided by curvelet transformation (140) of the image to represent the edges of collagen 
fibers, without segmenting the individual fibers. From computation of these curvelets, thus, scale, 
location and relative orientation of each fiber can be calculated (127). Tiff files that contained 
masks of the ERs [obtained through manual annotation, described in Section 6.4.2] were used in 
the ‘Boundary Method’ field within CurveAlign. The fraction of coefficients to keep, during CT 
computation, was set at 0.005 and the distance from the tumor edge, up to which fibers are 
analyzed, was set to 100 pixels or approx. 63 m . Before extraction of r , ERs were segmented 
out from all the core images so that the cellular structures within them did not interfere with the 
process of fiber extraction during curvelet transformation. 
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6.4.8 TACS3 measurement on TMA-3 using CT-FIRE and CurveAlign 
 As described in Results and Discussion, for detecting the TACS3 prognostic marker on 
cSLIM ( , )Z x y  maps the same general method as used in ref. (116)  was employed. We summarize 
that analysis method here. First, the ERs within each core were segmented out using its 
corresponding segmentation mask [see Section 6.4.2].  This was carried out to ensure that during 
subsequent fiber segmentation, cell edges did not interfere. CT-FIRE was then used to segment 
out all fibers within the ( , )Z x y  map of each core. Default parameters, as outlined in the CT-FIRE 
manual(132), were used except for the parameters labelled “thresh_im2” and “s_xlinkbox” for 
which values were set to 30 and 5 respectively. These fiber segmentation maps, along with ER 
segmentation masks, were then input to CurveAlign for extraction of fiber features. Features were 
computed for all fibers that were a distance of 100 m  from the tumor edge.  In CurveAlign, the 
“CT-FIRE Fibers” fiber analysis method was chosen and the “TIFF Boundary” was chosen as the 
boundary method. CurveAlign extracts a total of 34 fiber features as part of its standard 
computation. These features are related to the fiber curvature, width, length, density, alignment, 
proximity to epithelium and relative angle to epithelial boundary (116). As discussed in the Results 
and Discussion, core-level statistics derived from 3 features (related to alignment, proximity to 
epithelium and relative angle) were found to be the best predictors of DSS and DFS. The first of 
these features was the mean nearest alignment  , defined as the mean of the alignment of a fiber 
to its nearest 2, 4, 8 and 16 fibers. The algorithm for measuring the alignment of a fiber to its 
nearest neighbors has already been described in (116). The second feature used was the distance 
of each fiber to the nearest ER boundary, denoted l . The final feature was the relative fiber angle 
r . Means of   and l  and skewness of r , over each core, were used as predictors for SVM 
training [Section 6.3.5 of Results and Discussion]. 
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 For survival analysis, the Kaplan-Meier estimate was computed using an open-source 
MATLAB code (141). 
 
6.5 Summary and Conclusion 
 In summary, we have presented in this chapter cSLIM, a tissue imaging modality that 
provides stain-independent, quantitative markers of disease while preserving traditional 
histopathology images. Our instrument makes clinical translation of our disease markers easier by 
posing no new sample preparation requirements and providing traditional and novel markers in a 
single acquisition. Due to its modular design, the cSLIM instrument also requires fewer additional 
optical components than other label-free techniques and has higher throughput. We demonstrated 
that cSLIM normalized phase maps are stain-independent by comparing the results of phase 
imaging of tissue before and after staining. We also demonstrated that diagnostic and prognostic 
markers relevant to breast cancer can be extracted from cSLIM images through automated machine 
learning techniques. Since these disease markers are quantitative, they eliminate subjectivity from 
tissue evaluation. Because the analysis is automated, disease markers can be obtained by 
pathologists rapidly and reproducibly. Furthermore, by providing a fast and convenient means of 
extracting stromal collagen based prognostic markers, our instrument can potentially help 
pathologists predict disease aggressiveness in patients for whom other more traditional disease 
markers fail.   
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Chapter 7: Thesis summary and future work 
 
In summary, I have presented in this thesis instrumentation and computational tools that address 
some key limitations of/opportunities in traditional breast histopathology.   
Traditional breast histopathology for diagnosis is qualitative and manual, resulting in inter-
observer disagreement especially in cases that are difficult and when the tissue sample is small. 
The automated diagnosis scheme introduced in Chapter 4 relies on OPD based markers to perform 
quantitative histopathology for diagnosis. Relying on physical properties of tissue, this method 
performs an objective assessment of patient health and, being automated, can improve upon the 
throughput of existing evaluation methods. Previous attempts to quantify disease signatures for 
diagnosis have relied heavily on analysis of stained-dependent signals in images of tissue. The 
effect of stain variation complicates the process of automated detection in these approaches. While 
other label-free modalities have shown promise for breast cancer diagnosis, QPI has advantages 
over them in terms of speed, resolution, cost-effectiveness and compatibility with existing 
infrastructure in pathology labs. Furthermore, as I have demonstrated in Chapter 6, QPI can be 
used to obtain a stain-independent phase signal from stained tissue as well, which makes QPI based 
approaches even more attractive for clinical translation, once again due to the minimal disruption 
caused in existing methods.  
Future studies on diagnosis, building on the methods and tools discussed in this thesis, need 
to be focused on two fronts. Firstly, while I have demonstrated that detection of IDC and 
stratification of benign lesions (with atypia vs without atypia) is feasible using QPI based imaging 
markers, other breast lesions need to be taken into consideration. Testing the algorithms described 
for diagnosis in Chapters 4 and 6 for classifying different invasive breast carcinomas (ductal, 
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lobular, tubular etc.) as well as for separating BAH from DCIS are important considerations for 
the future. Secondly, while we showed in Chapter 6 that breast cancer diagnosis on stained tissue 
is feasible using our OPD based feature set, the robustness of the approach needs to be tested 
against stain variation from slide to slide and laboratory to laboratory. Obtaining stained samples 
from different labs, with potentially different staining protocols, and testing the feature set on those 
samples would be an important next step. 
On the prognosis front I have demonstrated in this thesis that tumor adjacent collagen-
based prognostic markers can be detected using QPI of breast tissue. As discussed earlier, due to 
the heterogeneous nature of breast cancers, traditional prognostic markers do not provide sufficient 
information on disease aggressiveness for some patients and these novel markers can help 
pathologists make better treatment decisions for such patients. QPI provides a faster and more 
convenient means for extracting these stromal markers in tissue compared to other methods such 
as SHGM. I also demonstrated that algorithms used to extract collagen markers in unstained tissue 
biopsies also work for normalized phase images of stained tissue. Thus, detection of these markers 
on stained tissue not only obviates the need for additional sample preparation but also allows   
traditional epithelial prognostic markers to be observed simultaneously with markers in tumor 
adjacent stroma. 
Futures studies related to imaging of collagen-based tissue biomarkers, extracted using 
QPI, can potentially look at correlations of these markers with other prognostic indicators such as 
histological grade and tumor molecular subtype. These studies can shed further light on epithelial-
stromal interactions responsible for invasion and metastasis in breast tissue. Using the cSLIM 
system, which generates both bright-field and phase images of whole-slides rapidly, studies like 
these involving large patient cohorts are feasible. In addition, since the tumor microenvironment 
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influences tumor progression in carcinomas of other organs as well, analysis of collagen fibers in 
pancreatic, colon, ovarian and prostate cancer are also worth pursuing. Such analyses have already 
been performed to varying extents by other researchers (56, 72, 142) in the past but the algorithms 
and instrumentation discussed in this thesis provide an unprecedented ability to look at large case 
sets and merge traditional markers with novel ones. 
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Appendix A: Analysis of dispersion in stained tissue 
 
 
 As discussed in the main text, the spectra of SLIM and cSLIM are different due to the 
effect of the spectral responses of the red, green and blue channels of the cSLIM system. This 
results in different values of both central wavelength 0  and coherence length cl  for the two 
systems even in absence of a stained tissue sample [Fig. 6.8 (a) and (b)]. Due to differences in 
absorbance between different parts of H&E stained tissue, the cSLIM 0  and cl are expected to 
change even further. Our results show that normalization of both stained and unstained tissue maps 
[using Eq. (6.2) in the main text] accounts for the differences between the SLIM and cSLIM 
spectra, making results from both modalities very similar. We discuss in this section reasons for 
why this normalization removes the stain dependent signal from phase images. 
 To explore this we first compute the pixel-wise spectra of light detected by the RGB camera 
when an H&E stained tissue core is imaged.  From the bright-field image measured by the camera 
[illustrated in Fig. A.1 (a)] we extract the red, green and blue channel images, ( , ), ( , )R x y G x y  and 
( , ),B x y  respectively. By dividing each image by the average signal in a 30 x 30 pixel background 
region, we are able to obtain the transmission images for three channels: ( , ), ( , )R GT x y T x y  and 
( , )BT x y  [Fig. A.1 (b)]. Fig. A.1 (c) shows the spectral response of the cSLIM system, in the 
absence of tissue, for the red, green and blue channels [ ( ), ( )R GS S   and ( )BS  , respectively]. This 
response includes both the filter response of the camera as well as the weights attached to the three 
channels numerically during computation of the equivalent grayscale image ( , )I x y  [Eq. (6.1) in 
the main text]. Thus, the cSLIM spectrum for ( , )I x y is the sum 
 
  ( ) ( ) ( ) ( ) ( ) ( ) ( )cSLIM ill R ill G ill BS S S S S S S      = + +    (A.1) 
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where ( )illS   is the illumination source spectrum, which is also the spectrum for SLIM imaging. 
( )cSLIMS   and ( )illS   were also depicted earlier in Fig. 6.8 (a).  
 
 
 
Figure. A.1 (a) Bright-field image of a stained TMA core. (a) Transmission maps for the red, 
green and blue channels. (c) Spectral response of cSLIM for the red, green and blue channels. (d) 
cSLIM spectrum at each pixel computed using Eq. (S2). 
 
 Assuming constant values of transmission for each spectral channel per pixel [ ( , )RT x y , 
( , )GT x y  and ( , )BT x y ] the spectral response for each channel in the presence of stained tissue can 
be calculated as - ' ( , , ) ( ) ( , )i i iS x y S T x y =  where , ,i R G B= .  Multiplying each response by the 
illumination spectrum ( )illS   and summing them gives us the pixel-wise cSLIM spectrum in the 
presence of tissue as  
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 ' ( , , ) ( ) ' ( , , ) ( ) ' ( , , ) ( ) ' ( , , ).cSLIM ill R ill G ill BS x y S S x y S S x y S S x y      = + +   (A.2) 
  This 3d spectrum is illustrated in Fig. A.1 (d). 
From ' ( , , )cSLIMS x y   we can compute the central wavelength map 0 ( , )x y  for the tissue core. By 
subtracting the mean value of 0  in a 30 x 30 pixel background region from 0 ( , )x y , we obtain 
the wavelength shift image 0 ( , )x y , illustrated in Fig. A.2 (a). This image shows that dispersion 
(variation of 0 in x  and y ) due to tissue absorbance is small. This is quantified by the histogram 
(computed over the foreground region consisting of tissue only) in Fig. A.2 (b) which shows a 
mean shift of 2.3 nm with a standard deviation of 1.5 nm. Dispersion also causes changes in 
coherence length cl  across the tissue. The image ( , )cl x y  can be obtained from ' ( , , )cSLIMS x y   by 
computing its autocorrelation function through Fourier transformation and measuring the FWHM 
of the function’s envelope [see Section 6.4.3]. The shift in coherence length ( , )cl x y  can be 
extracted from ( , )cl x y  by subtracting from it the mean value of cl in a 30 x 30 pixel background 
region. ( , )cl x y is shown in Fig. A.2 (c) and its histogram is shown in Fig. A.2 (d). A mean shift 
in cl  of  81.0 nm−  and a standard deviation of 58.3 nm was measured through this analysis. 
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Figure A.2 (a) Wavelength shift across the tissue core due to dispersion. (b) Normalized 
histogram of the image in (a) over the foreground (tissue region). (c) Shift in coherence length 
across tissue core due to dispersion. (d) Normalized histogram of the image in (c) over the 
foreground (tissue region). (e) Dispersion (shift in refractive index) in the stained tissue core. (f) 
Normalized histogram of the image in (e) over the foreground (tissue region). 
 
 This spectral analysis sheds light on why a simple division by the standard deviation of 
( , )x y  results in the stain-independent map ( , )Z x y [Eq. (6.2) in main text]. To begin with the 
slight difference in central wavelength between SLIM and cSLIM (589 nm vs 558 nm, see Section 
6.4.3) would indicate that cSLIM should have different phase values even in the absence of tissue 
absorbance. However, division of ( , )x y  by its standard deviation removes the wavelength 
dependent 01 /   factor (27): 
  
0
2
( , ) ( , )x y n x y t



=   ,  (A.3a) 
 
 
 
( , ) ( , )
( , )
( , )
n x y mean n x y
Z x y
std n x y
−
= ,  (A.3b) 
104 
 
accounting for the central wavelength difference between cSLIM and SLIM. In Eq. (A.3a), 
0( , ) ( , )n x y n x y n = −  refers to the pixel-wise difference between the refractive index of the tissue 
( , )n x y  and that of the surrounding medium 0n . t  is the thickness of the tissue section, assumed 
for simplicity to be constant. This assumption is reasonable for tissue biopsies that are cut to thin 
(4-5 m ) sections for histopathology (52, 56).  Here it is also assumed that refractive index is 
independent of wavelength which is a reasonable assumption, in the absence of tissue absorbance, 
for the small difference in the two central wavelengths between SLIM and cSLIM. 
 However, in presence of stained tissue, 0  itself is x  and y  dependent and does not cancel 
out when ( , )x y  is divided by its standard deviation. The normalized phase image for cSLIM in 
this situation, Z  , is thus given by 
  
   
 
0 0
0 0
0
0
0
, , ( , ) , , ( , )
( , ) ( , )
, , ( , )
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mean
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Z x y x y
n x y x y
std
x y
 
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
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  
−  
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(A.4b) 
where cSLIM is the cSLIM central wavelength ( 0  = 558 nm) in the absence of tissue dispersion, 
0 is the shift in central wavelength caused by staining  and n  is the shift in tissue refractive 
index due to stain induced dispersion.  
 Eqs. A.4 (a) and A.4 (b) would indicate the need for a local normalization constant rather 
than the global one we have used in our study. However, if 0  and n  are small valued and/or 
have weak x  and y  dependence, Z Z  . As shown in Fig. A.2, the x  and y  dependence of 0  
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is small (standard deviation of 1.7 nm over the image). To determine this for n , the following 
procedure was employed. The 3d spectrum ' ( , , )cSLIMS x y  , was first rescaled and resampled to 
obtain the frequency spectrum ' ( , , )
cSLIM
S x y   where 
2 c


= , c  being the speed of light. The same 
was done to ( )cSLIMS   to obtain ( )cSLIMS  . The transmission spectrum ( , , )T x y   was then obtained 
as 
' ( , , )
( , , )
( )
cSLIM
cSLIM
S x y
T x y
S



= .      (A.5) 
 From the transmission spectrum, the refractive index ( , , )n x y   can be obtained by using the 
Hilbert transform relationship between the real and imaginary parts of the electric susceptibility 
(143, 144). The procedure for this is outlined in ref. (143). The resulting refractive index is 
determined only up to an additive constant since the Hilbert transform of a constant is zero. Since 
we have knowledge of the central wavelength at each pixel [given by 0 ( , )x y ], the refractive index 
map ( , )n x y  at this central wavelength can be computed from ( , , )n x y  . Finally, by subtracting the 
refractive index map in absence of dispersion, ( , , 558 )cSLIMn x y nm = , from ( , )n x y  we get the shift 
in refractive index due to tissue absorption ( , )n x y . This subtraction also accounts for the 
differences in additive constants across the ( , )n x y  map caused by the computation of an 
independent Hilbert transform per pixel. ( , )n x y  is shown in Fig. A.2 (e) whereas Fig. A.2 (f) 
shows its histogram, once again computed only over the foreground (tissue region). As shown, not 
only is there a small shift in refractive index due to dispersion in tissue but the x  and y  dependence 
is also weak (standard deviation of 6.6 x 10-4).   
 We, therefore, conclude that our normalization works well despite tissue dispersion 
because of the small change in 0 , and thus in refractive index n , across the tissue core. Any 
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constant (spatially invariant) changes in both wavelength and refractive index are accounted for in 
( , )Z x y  by subtraction by the mean and division by the standard deviation of the raw phase 
( , ).x y  
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